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Abstract 
 
 
 
 
Tuning the pore architecture in 3-D polymeric scaffolds for tissue engineering 
is crucial for providing optimal frameworks for the seeded cells to organize into a 
functional tissue. 
Directional thermally induced phase separation (dTIPS) is a versatile and cost 
effective self assembly method for fabricating highly porous scaffolds of different 
materials, having fully tailorable porosity, and strongly anisotropic pore architectures.
 
Consequently, dTIPS scaffolds represent an ideal support for the growth of biological 
tissues that exhibit gradient morphology, such as bone, tendons, ligaments, nerves, 
liver, pancreas, and in particular blood vessels. The reconstruction of vascular grafts is 
in fact a prerequisite when the growth of thick tissues is needed. 
In the present work, we investigated the effect of the process parameters, such as 
cooling temperature (-30°C ≤ Tc ≤ +5°C), cooling time (2.5 h ≤ tc ≤ 32 h), and 
polymer concentration (1.5 to 6.5 wt%), on the pore microstructure of poly(L-lactic 
acid) (PLLA) 3-D scaffolds made by dTIPS. The scaffolds exhibited highly ordered 
dendritic domains, which are expected to act as guiding patterns for blood vessel 
sprouting. The same showed overall porosities up to 95%, and a degree of 
interconnectivity over 90%. By controlling the cooling regime, and polymer 
concentration we were able to tune the pore diameter up to 260 μm, while keeping the 
peculiar pore hierarchy unaltered. Specifically, pores of few tenths of microns were 
obtained at the largest tc, PLLA concentrations, and smallest Tc. On the other side, at 
the smallest tc and polymer concentrations, and keeping the system at Tc slightly 
below the solution freezing point, we managed to push the pore diameter up to 260 
μm. Scaffold compression modulus ranged between 1 to 8 MPa, with largest values 
recorded for samples with the smallest pore diameter, as expected. Finally, scaffolds 
were seeded with mesenchymal stem cells (MSCs) by means of vacuum-aided 
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method. The biological validation assessed after 7 days of culture in vitro evidenced 
massive scaffold colonization.  
In summary, we showed the possibility to scale up and down the pore architecture in 
dTIPS scaffold by one order of magnitude, by simple adjustments of the process 
parameters. This may allow creating a gradient porosity for in-growth of vascular 
tissue at any length scale (from macro to micro vessels) in one single construct. 
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Sommario 
 
 
 
 
In ingegneria tissutale, regolare l’architettura dei pori in scaffold 
tridimensionali polimerici è un fattore cruciale per fornire una struttura ottimale alle 
cellule seminate in modo tale che queste si organizzino in un tessuto funzionale. 
La directional thermally induced phase separation (dTIPS) è un metodo di self 
assembly versatile ed economico per la fabbricazione di scaffold ad alta porosità a 
partire da diversi materiali, avente la possibilità di regolare completamente la porosità 
ed di ottenere strutture porose fortemente anisotropiche. 
Di conseguenza, scaffold ottenuti tramite dTIPS rappresentano un supporto ideale per 
la crescita di tessuti biologici che mostrano morfologia anisotropia, come ossa, 
tendini, legamenti, nervi, fegato, pancreas ed in particolare vasi sanguigni. La 
ricostruzione di innesti vascolari è infatti un prerequisito quando l’obiettivo è la 
crescita di tessuti spessi. 
Nel presente lavoro, abbiamo investigato gli effetti delle variabili di processo, come la 
temperatura di raffreddamento (-30°C ≤ Tc ≤ +5°C), tempo di raffreddamento (2.5 h ≤ 
tc ≤ 32 h), e la concentrazione del polimero (da 1.5 a 6.5 wt%), sulla microstruttura 
dei pori di scaffold tridimesionali in poly(L-lactic acid) (PLLA) ottenuti per dTIPS. 
Gli scaffold hanno mostrato zone dendritiche ad elevato ordine, alle quali spetta il 
compito di fungere da struttura guida per i vasi sanguigni in crescita. Gli stessi hanno 
mostrato porosità totale fino al 95%, ed un grado di interconnessione maggiore del 
90%. Controllando il regime di raffreddamento, e la concentrazione del polimero 
siamo stati in grado di regolare il diametro dei pori fino ad un massimo di 260 m, 
mantenendo inalterata la sovrastruttura dei pori. Nello specifico, pori di poche decine 
di micron sono stati ottenuti con la maggiore tc, concentrazione di PLLA, e la minor 
Tc. Dall’altro lato, alla minore tc e concentrazione di polimero, e mantenendo il sistema 
alla Tc appena al di sotto della temperatura di congelamento, siamo riusciti a spingere 
il diametro dei pori fino a 260 m. Il modulo di compressione degli scaffold è variato 
iv 
 
tra gli 1 e 8 MPa, con i valori maggiori registrati, come da previsione, per i campioni 
con il diametro dei pori minore. Infine, gli scaffold sono stati seminati con cellule 
staminali mesenchimali (MSCs) tramite il metodo di vacuum-aided. La validazione 
biologica valutata dopo 7 giorni di cultura in vitro ha evidenziato una massiccia 
colonizzazione dello scaffold. 
Riassumendo, abbiamo mostrato la possibilità di aumentare o diminuire la struttura 
dei pori di un ordine di grandezza in scaffold ottenuti tramite dTIPS, tramite semplici 
variazioni dei parametri di processo. Questo può permettere la realizzazione di 
porosità lungo un gradiente per la crescita di tessuto vascolare a qualsiasi scala di 
grandezza (da vasi micro a macro) in una sola struttura. 
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Chapter 1 
 
Introduction 
 
 
 
 
1.1 Regenerative medicine and tissue engineering 
 
Recent advances in the knowledge of molecular and cellular mechanisms of 
diseases allowed the application of new efficient treatments against organ damage. 
Nevertheless, none of these treatments demonstrated to be decisive. The finding that a 
few stem cells are resident within each organ and can be activated when cell death 
occurs opened unexpected perspectives to highly innovative cell treatments 
potentially able to induce the reconstruction of the injured areas, rescuing the organ 
function. First attempts to inject stem cells within damaged organs confirmed only in 
part experimental data showing that several problems are still open in these so called 
cellular and molecular therapies. A new exciting and promising field, complementary 
to these therapeutic strategies, is represented by tissue engineering. 
Tissue engineering and regenerative medicine are often (and imprecisely) 
interchanged. They both share some of the knowledge and methods at the base of 
tissue science, but the second also includes self-healing through endogenous 
recruitment or exogenous delivery of appropriate cells, bio-molecules, and supporting 
structures. 
Since the term tissue engineering was firstly introduced in the late eighties, 
enormous progresses have been made, from the better understanding and harnessing 
of structure-function correlations in living organisms until the commercialization of a 
first-generation tissue-engineered medical products. 
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1.2 The tissue engineering approach 
 
Officially coined at a National Science Foundation (NSF) workshop in the fall 
of 1987, the term tissue engineering (TE), refers to "the application of principles and 
methods of engineering and life sciences toward fundamental understanding of 
structure-function relationships in normal and pathological mammalian tissues and the 
development of biological substitutes to restore, maintain or improve tissue function" 
[1]. 
The goal of tissue engineering is to repair or replace damaged organs or tissues 
by delivering functional cells, supporting scaffolds, growth promoting and signal 
molecules or their encoding DNA to areas in need. 
Tissue engineering has evolved from the use of biomaterials, which may repair 
or replace diseased or damaged tissue, to the use of controlled three-dimensional 
constructs, usually denominated scaffolds, in which cells can be seeded before 
implantation. These living tissue structures must tend to be functionally, structurally 
and mechanically equal to the tissue that must be replaced. The classic tissue 
engineering strategy is to isolate specific cells through a biopsy from a patient, to 
grow them on a bi-dimensional (2D) or three-dimensional (3D) bio-mimetic scaffold, 
under precisely controlled culture conditions, to deliver the construct to the desired 
site in the patient's body and to direct new tissue formation into the scaffold that can 
be degraded over time [2]. In order to achieve successful regeneration of damaged 
organs or tissues based on tissue engineering concepts, several critical elements 
should be considered, including the biomaterial scaffold that serves as a mechanical 
and biological support for cell growth and differentiation [2-4]. 
Strategies of TE can be classified as in vivo and in vitro. The first approach 
(also referred to as in situ generation), aims to create replacement tissue in the natural 
milieu. The goal can be accomplished by either cell transplantation [5-7], 
implantation or catheter-based  injection of cell seeded/unseeded scaffold [8-12], or 
through self-repair and healing promotion by delivery of or active molecules [13,14]. 
It is feasible and simpler but can be limited by poor control on graft development and 
outcome. 
Among the three pillars (scaffold, cells, bioactive molecules) which sustain 
tissue engineering, the function of the scaffold is crucial. This role is even 
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fundamental in the in vitro approach, where the resolution of problems related to the 
availability of suitable "biologized" scaffolds is preliminary to any further advance in 
the reconstruction of functionally efficient strips of tissue destined  to be engrafted in 
damaged organs. 
 
1.3 The Scaffold 
 
As seen, the scaffold plays a key role in the strategies dictated by TE. It is not 
surprising, at this point, to notice how much attention and expectations are put into 
scaffold design and characterization, from the choice of the material to the biological 
testing.  
Scaffolds may be composed of polymers, metals, ceramics or composites. 
Scaffold characteristics include high porosity, large surface area, structural strength, 
specific two or three-dimensional shape and biodegradability, if needed. Scaffolds 
can be manufactured in many forms to give the required characteristics for a variety 
of applications [15]. They can be tubular and flexible for nerves, blood vessels and 
intestine; stiff and opportunely shaped to match different types of bones and 
cartilage; jelly, in order to perfectly fit the wound that needs to be healed, and so on.  
Regardless its physical characteristics, a supporting scaffold has the main 
function to physically entrap cells into the specific area to be repaired, direct the 
spatial orientation of the extra-cellular matrix (ECM) components,  sustain and guide 
the growth of cells, and eventually provide part or all of the signals that are needed 
for cell proliferation, differentiation and cell-to-cell interaction [2,15]. An ideal 
device should mimic the extracellular matrix and, when biodegradable, it must be 
resorbed once the new tissue has formed around it [16].  
It must be designed by considering that the composition, structure and, 
therefore, the mechanical properties of the extracellular matrix can be specific to 
each organ or tissue [17,18]. In this optics, the adoption of decellularized ECM 
constructs can, better than any other support, fit this requirements. 
In summary, the term scaffold is usually referred to a 3D construct that must 
fulfill several requirements:  
- it must be biocompatible. 
- it must be able to bond with the host tissue without leaving any scar or non-
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adherent tissue, which means to be a class A bioactive material. 
- it should exhibit surface textures able to facilitate such bonds allowing a strong 
adhesion with cells and eventually the adsorption of biological metabolites.  
- its spatial structure (i.e., the scaffold architecture) must act as a template for 
tissue 3D growing up and it should consist of a thick web of interconnections and 
present a suitable porosity. Interconnections and porosities diameters ranging from 
30 to 80 μm and 50 to 300 μm respectively are sufficient for cells settlement to take 
place as well as for tissue development and vascularization and for nutrients/drugs 
delivering [24]. 
- its rate of degradation (if occurring) should ideally equal that of tissue 
regeneration. The degradation products should be non-toxic and easily ejectable from 
the body.  
- eventually, the dissolution process should stimulate the biochemical activity of 
the regenerating tissue in order to promote an efficient cells proliferation and 
differentiation (bioactivity). 
- scaffold mechanical properties should guarantee tissue regeneration even for 
regions subdued to static or dynamic loads. 
- scaffolds processing should allow their fabrication in different shapes in order 
to fit the damaged regions. 
- finally, the materials must possess the requirements imposed by the 
International Standards Organization (ISO) and from the Food and Drug 
Administration (FDA). 
An impressive number of different scaffolding philosophies for organogenesis 
have emerged to face the challenge of creating a biologized scaffold, and they can be 
enclosed in four main categories: (i) ex-novo fabrication of 3D bio-mimetic 
scaffolds, (ii) cell-sheet engineering, (iii) encapsulation devices, (iv) 
decellularization of pre-existing organic constructs and organ templating.  
A brief introduction to these approaches is now presented. The scaffolding 
methodology adopted in the current work belongs to first, and wider of the 
mentioned categories, and will be discussed in detail in §1.4.  
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1.3.1 Cell sheet engineering 
 
Cell-sheet engineering is centered on the use 2D support made of biocompatible 
thermo-responsive polymers like poly (N-isopropyl acrilamide) (PNIPAM), that can 
change their physical properties once they are subjected to a temperature change. 
These materials are biocompatible but non-biodegradable and thus serve as pure 
support for the constitution of 2D cell sheets. In particular, their temperature-driven 
water affinity is exploited for culturing and assembling cellular mono-layers to create 
a thick tissue (cell-sheet® engineering) [18]. This pioneering technology has been 
systemically applied to several of applications such as cornea [19] in clinical trials 
and myocardium [20] in preclinical trials. The main advantages of the cell-sheet 
engineering include the non damaging nature of the cultured cell/tissue harvesting 
method, the possibility to obtain homogeneous and cell dense tissues,  and to 
perform suture-less implantations. The difficulty to pre-assemby thicker tissues in 
vitro represent the main limitation of this method. Beside the time consumption 
(each cell layer is about 30 µm thick), cell death was demonstrated to take place in 
the core layers, due to poor perfusion. [21] On the other side, in situ approach would 
require multiple surery which is unlikely for the recipients.  
 
1.3.2 Cell encapsulation 
 
Encapsulation devices have been experimented for over several decades and 
principally served as immune-isolating vectors during allogenic or xenogenic cell 
transplantation [22,23] without the need for immunosuppression and its 
accompanying effects, or for drug delivery and controlled-release purposes [24]. 
Encapsulation is a process through which cell or factors are physically entrapped 
within a semi-permeable membrane or within a homogenous solid mass [22,24,25]. 
The biomaterials typically used for encapsulation are hydrogels, which are formed by 
covalent or ionic crosslinking of water-soluble polymers. One important feature of 
encapsulation is the possibility of scaffold  self-assembling from liquid monomers to 
solid polymer meshwork upon initiation, upon ionic strength, temperature, light, or 
pH. Provided that the conditions inducing the hydrogel formation or the 
polymerization are compatible with living cells, encapsulation allows to  perform 
6 
 
scaffold fabrication and cell seeding at once, since cells and liquid biomaterials can be 
mixed before initiation of polymerization. Other relevant advances are the 
homogeneity of cell distribution in the hydrogel and excellent cell viability. 
Moreover, this self-assembled approach enables injectable application where the 
polymerization can be initiated after injection, thus allowing scaffold shaping to fit 
the wound. However, a great limit of this technique is related to the lack of adequate 
mechanical properties which prevent this scaffolds from being used in load bearing 
tissue repair/reconstruction. 
 
1.3.3 Organ templating 
 
A cellular extra-cellular matrices (ECMs) can be collected from allogenic or 
xenogenic tissues to act as template for addressing cell growth and differentiation. 
This approach has recently emerged as revolutionary and powerful and tool for TE. It 
has been used for the reconstruction of many tissues, such as heart valves [26], 
vessels [27], nerves [28], tendon and ligament [29]. This scaffolding method consists 
in removing the allogenic or xenogenic cellular antigens from the tissues which may 
provoke immunogenicity upon implantation, while preserving the ECM components, 
which are common among species and therefore immunologically tolerated. The 
major advantage of this scaffolding approach is surely resides in the excellent 
mimetic mechanical and biological properties of the decellularized ECM. 
Moreover, the presence of residual growth factors in the decellularized matrix 
may further facilitate cell growth and remodeling [30]. Concerns about this method 
include in primis, the risk of immunogenic reaction and rejection of the implant, due 
to incomplete removal of cellular components [31]. In addition, many of the issues 
related to synthesized porous scaffold continue to persist for this approach. Cell non-
uniform distribution within the decellularized ECM, and in some cases, the need of 
vascular networks, may lead to the constitution of inhomogeneous tissues. 
  
7 
 
1.4 Fabricating novel 3D bio-mimetic porous scaffolds 
1.4.1 Introduction 
 
Ex-novo fabrication of 3D scaffolds is probably the more challenging but 
extensively investigated area of TE.  
The principal advantage of this approach relies in the possibility to fully design 
the supporting device, thus conferring to the scaffold predictable shapes, mechanical 
properties, compartmentalization, surface topologies and functionalities for any 
given application.  
If, on one side, the all-around tailoring ability makes this approach potentially 
suitable for reconstructing every type of tissue, it also undiscloses thousands of new 
question about which the correct paradigm should be.  
Another issue is related to the integration of the engineered scaffolds with the 
cellular systems. The in vitro scaffold passive culturing is generally a time-
consuming and poorly efficient practice, and tends to produce inhomogeneous cell 
engraftments and tissues.  
The adoption of dynamic bioreactors and perfusion chambers (§1.6) can only 
partially meet the need of  higher cell seeding efficiency, while introducing new 
problems related to the cost of the apparatuses, as well as the low cell viability. 
Furthermore, cell death can occur in the core region of the synthesized tissue, due to 
the lack of a vascular net and poor perfusion. This hurdle, which also afflicts the 
other scaffolding approaches, is what mostly prevents 3D scaffolds to be 
systematical used in organ repair. 
 
1.4.2 Scaffold fabrication methods  
 
The scaffold suitability for a given clinical application is not only determined 
by the choice of the material with the proper physico-chemical and mechanical 
properties, but also strongly depends on the processing routes applied to the chosen 
materials [2, 32-35] 
Materials processing can be performed by a multitude of techniques. The 
extent to which new materials can be created, engineered and shaped is only limited 
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by imagination. 
Some of the most currently in vogue routes for scaffold manufacturing, which 
can be easily found in literature, are: foaming techniques (solvent casting and 
particulate leaching [36], phase separation [37], gas foaming [38], etc.); bottom-up 
strategies like rapid prototyping (3D printing [39], pressure assisted micro-syringe 
[40], etc.), soft-lithography (micro-molding [41], micro-fabrication [42], spin casting 
and membrane lamination [41,43], etc.), and self-assembly (pneumatic [44] and 
electrical fiber spinning [45], emulsification/freeze-drying processes [46], fiber 
bonding [47], etc.); top-down approaches (selective laser sintering [48], etc.), and so 
on. Some of the mentioned techniques represent the core subject of this work, and 
will be later and more in depth discussed.  
 
1.4.3 Degradation  
 
Once implanted, the biodegradable material-based device should maintain its 
mechanical properties until it is no longer needed and then be absorbed and excreted 
by the body [49]. Controllable degradation of substrate scaffold is important to the 
ultimate clearance of the synthetic implant materials within an engineered tissue 
[50,51]. Simple chemical hydrolysis of the hydrolytically unstable backbone is the 
prevailing mechanism for the polymer's degradation. This occurs in two phases. In 
the first phase, water penetrates the bulk of the device, preferentially attacking the 
chemical bonds in the amorphous phase and converting long polymer chains into 
shorter water-soluble fragments. Since this takes place in the amorphous phase 
initially, there is a reduction in molecular weight without a loss in physical 
properties, being the device matrix is still held together by the crystalline regions. 
The degradation of the physical properties occurs as water begins to fragment the 
device. 
 In the second phase, enzymatic attack and metabolization of the fragments 
occurs, resulting in a rapid loss of polymer mass. This type of degradation, i.e., when 
the rate at which water penetrates the device exceeds that at which the polymer is 
converted into water-soluble materials, resulting in erosion throughout the device, is 
called bulk erosion. All of the commercially available synthetic devices and sutures 
degrade by bulk erosion.  
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A second type of biodegradation, known as surface erosion, occurs when the 
rate at which the water penetrates the device is slower than the rate of conversion of 
the polymer into water-soluble materials. Surface erosion results in the device 
thinning over time while maintaining its bulk integrity. Polyanhydrides and 
polyorthoesters are examples of materials that undergo this type of erosion, i.e., 
when the polymer is hydrophobic, but the chemical bonds are highly susceptible to 
hydrolysis. In general, this process is referred to in the literature as bio-erosion rather 
than biodegradation [52].  
Generally, the degradation-absorption mechanism is the result of many 
correlated factors, including:  
– the chemical stability of the polymer backbone.  
– the presence of catalysts, additives, impurities, or plasticizers.  
– the geometry of the device. 
Balancing these factors by tailoring an implant to slowly degrade and transfer 
stress at the appropriate rate to surrounding tissues as they heal is one of the major 
challenges facing researchers today.  
 
1.5 Cell sources for tissue engineering 
1.5.1 Introduction 
 
The reconstruction of a given tissue type needs several aspects to be 
considered, including, the function of the tissue, the mechanical requirements, such 
as load and flexibility, the specific environment in which the tissue is located, etc. 
Among them, the identification of a suitable cell source for obtaining the specialized 
cell types within the tissue, is priority. 
The ideal cell required for tissue engineering must show good self-regenerative 
potential, the ability to functionally replace the damaged tissue and must be readily 
available in desired quantity. 
The versatility of TE provides for addition of cells sourced from the same 
recipient (autologous cells), from a genetically non-identical individual of the same 
species, (allogeneic cells), and  from an individual belonging to another specie 
(xenogeneic cells, e.g., from pigs to human [53]), to the produced devices. 
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Safety issues to recipients of autologous cells implants (autografts) are 
generally limited to acquisition of adventitious agents (microbial, viral, etc.). On the 
other hand, the possibility of allogeneic or xenogeneic cells implants (allografts and 
xenografts, respectively) opens to the risk of transmission of pathogens from 
nonautologous donors (§1.7). 
 Among others, the use of stem cells (§1.5.2) has catalyzed enormous attention 
in TE, due to the unique properties which characterize these cells respect to 
differentiated cell models. In particular, the possibility to derive different tissue types 
from one single stem type, offers unprecedented possibilities in the optics of organ 
reconstruction. Stem cells for TE include adult stem cells, such as bone marrow 
stromal (mesenchymal) stem cells, embryonic stem (ES) cells or germ (EG) [54]. 
However, the most appropriate mixture of growth factors and physical stimuli to be 
combined to lead undifferentiated cells to a specific phenotype is still under debate.  
 
1.5.2 Stem cells: definition and classification 
 
Stem cells are a population of immature tissue precursor cells which are 
capable of self-renewal or proliferation as well as of differentiation into a spectrum 
of different cell types, under specific conditions [55]. In general, they possess the 
following characteristics: i) high capacity for self-regeneration, and ii) the highest 
potential for differentiation, iii) the ability to be cultured ex vivo and used for tissue 
engineering, and iv) plasticity (the ability to trans-differentiate [56].  
On the basis of their potential towards differentiation , stem cells may be 
classified into four categories: 1) totipotent, 2) pluripotent, 3) multipotent and 4) 
monopotent or oligopotent.  
Totipotent stem cells have the potential to differentiate into cells of all three 
embryonic layers: endoderm (interior stomach lining, gastrointestinal tract, the 
lungs), mesoderm (muscle, bone, blood, urogenital), or ectoderm (epidermal tissues 
and nervous system). If implanted in a functional uterus, a totipotent cell can 
generate an entire body, provided with a central and peripheral nervous system. In 
mammals, the only totipotent stem are zygotes at an early stage of cell division 
(blastomeres). With the progression of differentiation, zygotes tend to form cell 
layers inside and outside of the embryo.  
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The cells belonging to the inner layers are called pluripotent Pluripotent stem 
cells can give rise to any fetal or adult cell type. However, alone they cannot develop 
into a fetal or adult animal because they lack the potential to contribute to extra-
embryonic tissue, such as the placenta [57]. As they continue to divide and to further 
specialize, they become the specific-tissue progenitors. At this stage, they are 
multipotent cells, since they can differentiate into different cell types within a given 
organ. For example, blood stem cells or multipotent hematopoietic stem cells can 
differentiate into red cells, white cells or platelets.  
Finally, monopotent or oligopotent stem cells, can only lead to one or a few 
types of specialized cells. However, they have the property of self-renewal which 
distinguishes them from non-stem cells (e.g. muscle stem cells). 
 
1.5.3 Stem cell sources: embryonic and adult stem cells 
 
On the basis of their origin and biological properties, stem cells can be also 
classified into embryonic stem cells and adult stem cells 
Embryonic stem cells derive from the internal layer of the blastocyst (a post-
zygotic early embryonic stage) [58]. These cells possess the ability to proliferate in 
an undifferentiated state for long culturing periods. Moreover, a single ESC can 
develop in more than 200 cell types and, therefore, in different tissues or organs, 
under favorable conditions, due to their  powerful differentiation capacity [59]. ESCs 
can be harvested from three sources: aborted fetuses, embryos discarded after in vitro 
fertilization and embryos specifically created in laboratory for stem cells production. 
In vitro differentiation of human embryonic stem cells in cardiomyocites was 
demonstrated by Kehat et al [60].  
Adult stem cells are undifferentiated cells that reside in a specialized tissue or a 
developed body and are able to specialize into any of the cells of the tissue or body 
from which they originate. Due to their ability to self-regenerate, these cells 
constitute a repair system which allows tissues to maintain their stability and 
function, by replenishing specialized cells, but also maintaining the normal turnover 
of regenerative organs (such as blood, skin or intestinal tissues, etc.). Sources of 
adult stem cells include self-regenerating tissues such as bone marrow, blood, 
epidermis, but even tissues such as brain or liver. 
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1.5.4 Humans stem cells: ethical and clinical issues 
 
There exist several ethical problems associated with the collection of human 
embryonic stem cells (hESCs), mainly related to the inevitable destruction of the 
originary source (i.e., the embryo) [54]. The tout court equalization of the human 
embryo state to the adult state, has raised a controversial dispute within the scientific 
(and not) community, leaving unresolved fundamental moral and legal issues related 
to the usage of hESCs, beside affecting either the liberty of research and religious 
beliefs of the individual researcher. The decision to carry out experimentation on 
hESCs is delegated to the single countries. It's worthy to mention US recent change 
of policy, with the settlement of the new democratic government. The US adoption 
of a regulated liberalization in the use hESC could serve as a guide model and 
hopefully have resonance in other countries, including Italy. Other potential barriers 
to the use of these cells relate to the need for the receivers to undergo 
immunosuppressive therapies, due to embryonic stem cells to be potentially 
allogeneic. The uncontrolled differentiation of these cells may also represent a hurdle 
to their extensive use [61].  
Adult stem cells do not involve the previously mentioned ethical or 
immunological concerns, as, in this case, donor and recipient coincide and none of 
them has to (or at least shouldn’t) be sacrificed. However, respect to their embryonic 
counterpart, the capacity for proliferation and differentiation is lower. Furthermore, 
they are often difficult to identify, isolate and purify and are often not sufficiently 
numerous for clinical transplantation without in vitro expansion. This also may 
represents a problem since adult stem cells do not replicate indefinitely in culture 
[62]. 
 
1.6 Bioreactors 
 
A widely supported finding is that the three-dimensional architecture of a 
tissue is not only determined by the scaffold structural and chemical stimuli, but also 
depends on subjecting the cells to physiological stress during cultivation. Growing 
blood vessels, for example, must be exposed to compression, shear stresses and a 
pulsated flow of the culture medium to acquire their mechanical properties [16,63]. 
13 
 
In order to match most of these requirements, cell seeded scaffolds are often treated 
in bioreactors until the tissue or organ is fully developed. To improve the results of 
the in vitro approach and manage to grow three-dimensional living constructs that 
contain more than a few layers of cells, researchers have implemented various types 
of bioreactors, each one simulating a different fluido-dynamical state and thus 
characterized by a different geometry of the container. A typical and largely diffused 
container for dynamic culturing is the spinner flask, which is nothing but a shaken 
flask (usually at 50 rpm). In such containers, the cell constructs are subjected to 
turbulent mixing in presence of proper fluids that provide a well-homogenized 
environment around the cells, thus minimizing the settling of stagnant layer nearby 
 
 
Fig. 1.6.1: A diffused design of dynamic bioreactor: Spinner flask 
 
the surface. It been shown that the cultivation of cardiac cell constructs in spinner 
flask produces engineered tissues that are superior in almost every aspect (aerobic 
metabolism of cells, DNA content, metabolic activity and morphological appearance) 
compared to tissues grown in static conditions [64]. The spinner flask, however, may 
not be the best device for the cultivation cells. The turbulent flow of fluid to the 
surface of the cell constructs is usually characterized by local vortexes 
that can destroy the implanted cells. 
More complex bioreactors combined with mechanical signals such as stretching 
or compression, have proven to their effectiveness in enhancing the proliferation and 
distribution of seeded human cardiac cells through the entire volume of the scaffold, 
by further stimulating the formation and organization of ECM graft [65,66]. These 
encouraging achievements, however, must face some difficulty. Many bioreactors are 
unable to provide sufficient oxygen and nutrients to tissue growth. The growth in a 
bioreactor typically stops once the tissue has reached a thickness of 100μm, 
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corresponding to about 6-10 layers cellular [21,67]. Beyond this thickness, the cells of 
the central layers are too far away because the addition of fresh medium can take hold 
there. Therefore future bioreactors for tissue engineering should combine perfusion 
and mechanical stimulation, for example allowing adjustable movement pulsatile and 
variable levels of pressure.  
  
 
 
1.7 Safety concerns and regulatory issues: the role of FDA 
 
Multidisciplinary character of TE raised intrinsic concerns about validity and 
safety of TE therapies. In fact, although acellular biomaterials or drugs have many 
predicates, virtually all TE therapies have no predicates. Consequently, no standards 
exist by which these strategies may be assessed for safety and effectiveness prior to 
their application.  
Despite the lack of standards for assessment, the responsibility of U.S. Food and 
Drug Administration (FDA) to protect the public from health risks associated with 
investigational therapies remains unchanged.  
FDA’s responsibility requires that new therapies approved for use in the United 
States be safe and effective.  
Safety criteria for medical devices require that probable benefits to health 
outweigh probable risks of the therapy itself, or the untreated diseases. For example, 
many systems for cell culture contain animal-derived components, and other 
biological or chemical contaminants may derive from the scaffold material or result 
from the combined cell-scaffold action upon interaction. In addition, if allogenic or 
xenogenic cells are included, transmission of adventitious agents may occur. Both the 
patient and the working staff must be protected from possible pathogens.  
In the effort to guarantee as much as possible the safety of TE therapies,  FDA 
has applied several standards, principally from the Center of Biological Evaluation 
and Research (CBER) [68], which establish precise regulatory respect to media 
components, tissue acquisition, implant handling and storage, and safety validation of 
the final products. 
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For non-autologous therapies, safety standards have been established for 
conventional banking of human and non-human tissues or tissue extracts. For 
allogeneic tissues, these standards are similar to blood banking, and require the 
screening of donors for multiple pathogens like HIV, and hepatitis type B and C [68-
70].  
In addition to safety issues regarding pathogen transmission, in the case of xenogeneic 
tissues, immunogenicity and stability of transgenic vectors must be assessed [71]. 
This subject deserves great attention, since the use of xenogeneic tissues holds 
potentials of enormous supply of tissues from many different species or transgenic 
animals.  
Effectiveness criteria for devices should demonstrate that use of the device for 
its meant uses, and conditions for use, restore as much as possible of the physiological 
deficiency caused by the disease in a significant portion of the target population [72]. 
Tissue-engineered devices may require assessments different from those for 
nonliving, non-resorbable implants (ceramic or metallic hip and knee joints, 
polymeric vascular grafts, etc.) These kind of prosthetic devices are meant to remain 
and interface indefinitely with the host tissue and their efficacy is typically stable, and 
durable. On the other hand, most tissue-engineered implants are constituted by a 
resorbable and a cellular component. Although well-characterized standards exist for 
the breakdown of acellular biodegradable polymers (e.g., poly(L-lactic acid) [73], 
addition of cells to either FDA approved or non approved polymers may require both 
preclinical and clinical assessments.  
These regulatory standards apply to tissue-engineered therapies just as for 
conventional medical devices, drugs, or biologics. However, the composite nature of 
most TE therapies complicates FDA’s evaluation of their safety and effectiveness. For 
this reason, FDA will be asked to provide new approaches for establishing standards 
and regulatory protocols for TE. 
 
1.8 Aim of the present work  
 
Background 
The emergence of TE as an academic discipline and global industry, has 
opened unprecedented possibilities for the development of advanced therapies in the 
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treatment of congenital and acquired diseases [1,2,3,4,74]. Up to date, encouraging 
results have been obtained in fully reconstructing hard tissues, such as bone [75] and 
cartilage [76], and flat soft tissues, such as cornea [77] and skin [78], while more 
complicated soft tissues (heart, as an example) are far more challenging to be 
replicated in vitro. Several TE strategies have been successfully proposed for tissue 
reconstruction (§1.3), such as the overlaying of several bi-dimensional sheets of 
differentiated cells, cell entrapment in self-assembling hydrogels, and cell 
engraftment on pre-constituted decellularized templates. The other approach, as said, 
relies in the use of biodegradable bio-mimetic 3D scaffolds, and constitutes the 
subject of this work.  
Set in this scenery, my research proposed to tailor and to test biocompatible 
polymer based constructs, destined to host, address and sustain the proliferation of 
human cellular colonies in vitro. 
 
Description of the work 
The work has been done at National Institute for Material Science (NIMS) in 
Tsukuba City, Japan.  
Preliminary experiments aimed at reproducing and mastering the scaffold 
fabrication techniques: thermally induced phase separation.  
 The work carried out after this initial period was focused on the further 
development and optimization of the fabrication technique as well as to the 
overcoming of the several problems related to the fabrication routes. These scaffolds 
were subjected to deeper characterizations (mechanical and biological viability) 
while ameliorations were brought to the synthesis protocols. 
 
Scaffolds by thermally induced phase separation (TIPS) 
One of the main unresolved problems of TE is the difficulty in reconstructing 
healthy thick tissues. Usually, if constructs do not allow oxygen perfusion, no more 
than three cell layer can grow in vitro without occurring of necrosis in the core layers 
[21]. As a result, while a number of bio-supports processed by many different 
techniques have been successful in hosting a multitude of cell systems, while only 
few of them have proven their potential capability in maintaining cell cultures over 
time [79,80].  
No flourishing civilization could exist far from a river. For these same reasons, 
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beside the capability of supporting cell growth, expansion, and differentiation, the 
scaffold should primarily guarantee perfusion, vascularization, growth factor 
delivery, and all those processes responsible for cellular long term retention [81,82]. 
This convictions animated my research on 3D scaffolds for TE, in the effort to 
incorporate in a single construct the information able to trigger the specific tissue 
reproduction. Such a scaffold should be able to exhibit hierarchical porosities, at the 
millimetre scale to help nutrition and vascularization, at the micrometer scale to 
accommodate cells, and at the nanometre scale to favour the expression of extra-
cellular matrix components, with the desired chemical and mechanical functions 
[83]. Most of these requirements were matched with the adoption of directional 
Thermally Induced Phase Separation as synthesis method. 
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Chapter 2 
 
Materials and methods 
 
 
 
 
2.1 TIPS 
 
The main limiting factor of 3D scaffolds for growing in vivo healthy thick 
tissues is represented by the lack of perfusion into the core regions of the construct, 
resulting in poor colonization and cells confinement on the cortical layers of the 
scaffold. The lack of a suitable pore arrangement able to facilitate capillary diffusion 
of growth factors and nutrients, is among the principal causes, together with the 
scaffold inability to host more organized structures like blood vessels [15,81]. 
In this research, a multitude of attempts were done, all aimed at the 
implementation of original solutions to the optimal architecture dilemma [83]. With 
respect to poly(lactic acid) (PLLA) a large number of processing techniques have 
been reported, including gas foaming [84], solvent casting and particulate leaching 
[85], fiber bonding [47], electrospinning [86,87], soft-lithography [41], and phase 
separation [88]. In particular, lactide-based scaffolds made by thermally induced 
phase separation (TIPS) have demonstrated their suitability to host cell systems. 
Their multi-scale porosity is potentially capable of supporting cell-matrix interaction 
at any biological level (Fig. 2.1.1) [83,89]. 
As schematically shown in Fig. 2.1.2, TIPS is basically a three step process in 
which a homogeneous polymer-solvent solution is brought to phase separate upon 
the application of a thermal gradient into a polymer-rich phase and a solvent-rich 
phase. Porosity is obtained by leaching out the solvent phase by exposing to a second 
specific solvent that acts as a non-solvent for the polymer. The driving force of the 
process relies in the alteration of the thermodynamic equilibrium imposed by the 
under cooling that causes polymer solubility to decrease within the solvent phase 
undergoing solidification. 
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Fig. 2.1.1: Scaffolds made by thermally induced phase separation provide for a multi-scale porosity in 
a single construct, which make them suitable for supporting a variety of biological functionalities 
 
A number of ternary systems have been investigated for producing polymeric 
structures by TIPS [90,91]. In particular, for PLA-based systems, the use of dioxane 
as the polymer solvent turned out to be the election choice, due to its relatively high 
melting temperature (T = 11.8°C) and ease of removal. Moreover, it has been 
demonstrated that dioxane can crystallize into different geometries depending on its 
concentration within the polymer solution and quenching conditions [89].
 
The ability 
to control solvent shaping under solidification is crucial because crystallite geometry 
and order act as template for porosity. It has been observed that the imposition of  an 
anisotropic thermal gradient to the polymeric solution can force dioxane 
crystallization along specific directions, thus conferring a higher degree of order to 
the whole system at a macroscopic level [92]. Several research groups managed to 
obtain densely packed arrays of parallel micro channels by applying uni-directional 
TIPS to mixed PLA and PLGA solutions in dioxane [93-95]. 
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Fig 2.1.2: Step-preparation of PLLA porous scaffold by thermally induced phase separation. 
 
However, this configuration may represent an obstacle for intense cell-to-cell 
signalling between adjacent channels, or even result in short-term cells viability in 
the case of inadequate nutrient supply/diffusion through the micro-cavities of the 
inner walls. In addition, cells constriction to a mono-dimensionally ordered 
displacement may impede cells arrangement into more complex structures or prevent 
vessels capillary sprouting. 
In this optics, the set of TIPS conditions identified and adopted in the present 
work, corresponds to a porosity arrangement that more than others would better 
support diffusive phenomena as well as suit blood vessels accommodation, thus 
easing angiogenesis promotion.  
 
 
2.2 Scanning Electron Microscopy (S.E.M.) 
 
Essential components of all SEMs include the following: 
- Electron Source ("Gun") 
- Electron Lenses 
- Sample Stage 
- Detectors for all signals of interest 
- Display / Data output devices 
- Infrastructure Requirements: 
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 Power Supply 
 Vacuum System 
 Cooling system 
 Vibration-free floor 
 Room free of ambient magnetic and electric fields 
SEMs always have at least one detector (usually a secondary electron detector) 
 
 
 
Fig 2.2.1: Schematic drawing of the electron and x-ray optics of a combined SEM-EMPA 
 
In a typical SEM, an electron beam is thermionically emitted from an electron gun 
fitted with a tungsten filament cathode. Tungsten is normally used in thermionic 
electron guns because it has the highest melting point and lowest vapour pressure of 
all metals, thereby allowing it to be heated for electron emission, and because of its 
low cost. Other types of electron emitters include lanthanum hexaboride (LaB6) 
cathodes, which can be used in a standard tungsten filament SEM if the vacuum 
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system is upgraded and field emission guns (FEG), which may be of the cold-cathode 
type using tungsten single crystal emitters or the thermally-assisted Schottky type, 
using emitters of zirconium oxide. 
The electron beam, which typically has an energy ranging from 0.5 keV to 40 
keV, is focused by one or two condenser lenses to a spot about 0.4 nm to 5 nm in 
diameter. The beam passes through pairs of scanning coils or pairs of deflector plates 
in the electron column, typically in the final lens, which deflect the beam in the x and 
y axes so that it scans in a raster fashion over a rectangular area of the sample surface. 
When the primary electron beam interacts with the sample, the electrons lose 
energy by repeated random scattering and absorption within a teardrop-shaped 
volume of the specimen known as the interaction volume, which extends from less 
than 100 nm to around 5 µm into the surface. The size of the interaction volume 
depends on the electron's landing energy, the atomic number of the specimen and the 
specimen's density. The energy exchange between the electron beam and the sample 
results in the reflection of high-energy electrons by elastic scattering, emission of 
secondary electrons by inelastic scattering and the emission of electromagnetic 
radiation, each of which can be detected by specialized detectors. The beam current 
absorbed by the specimen can also be detected and used to create images of the 
distribution of specimen current. 
These signals include secondary electrons (that produce SEM images), 
backscattered electrons (BSE), diffracted backscattered electrons (EBSD that are used 
to determine crystal structures and orientations of minerals), photons (characteristic 
X-rays that are used for elemental analysis and continuum X-rays), visible light 
(cathodoluminescence--CL), and heat. Secondary electrons and backscattered 
electrons are commonly used for imaging samples: secondary electrons are most 
valuable for showing morphology and topography on samples and backscattered 
electrons are most valuable for illustrating contrasts in composition in multiphase 
samples (i.e. for rapid phase discrimination). X-ray generation is produced by 
inelastic collisions of the incident electrons with electrons in discrete ortitals (shells) 
of atoms in the sample. As the excited electrons return to lower energy states, they 
yield X-rays that are of a fixed wavelength (that is related to the difference in energy 
levels of electrons in different shells for a given element). Thus, characteristic X-rays 
are produced for each element in a mineral that is "excited" by the electron beam. 
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Electronic amplifiers of various types are used to amplify the signals which are 
displayed as variations in brightness on a cathode ray tube. The raster scanning of the 
CRT display is synchronized with that of the beam on the specimen in the 
microscope, and the resulting image is therefore a distribution map of the intensity of 
the signal being emitted from the scanned area of the specimen. The image may be 
captured by photography from a high resolution cathode ray tube, but in modern 
machines is digitally captured and displayed on a computer monitor and saved to a 
computer's hard disk. 
The SEM is also capable of performing analyses of selected point locations on the 
sample; this approach is especially useful in qualitatively or semi-quantitatively 
determining chemical compositions (using EDS), crystalline structure, and crystal 
orientations (using EBSD). The design and function of the SEM is very similar to the 
EPMA and considerable overlap in capabilities exists between the two instruments. 
SEM analysis is considered to be "non-destructive"; that is, x-rays generated 
by electron interactions do not lead to volume loss of the sample, so it is possible to 
analyze the same materials repeatedly. 
The SEM is routinely used to generate high-resolution images of shapes of 
objects (SEI) and to show spatial variations in chemical compositions: 1) acquiring 
elemental maps or spot chemical analyses using EDS, 2)discrimination of phases 
based on mean atomic number (commonly related to relative density) using BSE, and 
3) compositional maps based on differences in trace element "activitors" (typically 
transition metal and Rare Earth elements) using CL. The SEM is also widely used to 
identify phases based on qualitative chemical analysis and/or crystalline structure. 
Precise measurement of very small features and objects down to 50 nm in size is also 
accomplished using the SEM. Backescattered electron images (BSE) can be used for 
rapid discrimination of phases in multiphase samples. SEMs equipped with diffracted 
backscattered electron detectors (EBSD) can be used to examine microfabric and 
crystallographic orientation in many materials. [96-99] 
2.3 Materials for scaffold synthesis 
 
The choice of the material destined to 3D scaffold ex-novo fabrication for TE is 
a crucial issue and mainly depends on the kind of application required, i.e. the type 
of tissue to mimic. The past several years have witnessed the explosion of the 
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material science applied to tissue engineering [96]. Many natural substances are 
proving valuable, while the world of synthetic materials, mostly polymeric, has 
completely opened up.  
In comparison to attachment of adherent cells to a rigid and smooth surface, 
greater extent of attachment, survival, and function can be achieved by cell adhesion 
on and porous (either soft or stiff) and roughness-controlled substrates, that resemble 
the macro-molecular structure of extra-cellular matrix [97-99]. Base materials used 
as substrates in TE may be divided into natural (collagen, albumin, hyaluronic acid, 
fibrin, chitosan, silk, alginate, ecc.), synthetic (poly-lactide acid, poly-glycolide, 
poly- caprolactone, poly-N-isopropyl acrilamide, hydroxyapathite, ceramic glasses, 
ecc.), and semi-synthetic or hybrid materials.  
Each material is accompanied by a series of pros and cons which determine its 
usage or not for a specific application. The advantage of naturally derived polymers 
resides in their close compatibility with ECM environments, thus providing better 
supports for ex-vivo cultures of cells. However, they typically lack the necessary 
mechanical integrity for fabrication into scaffolds or other differently shaped 
polymer structures. They also suffer from the limitation of sufficient supply and 
source variation, which limits their use for TE. Some naturally derived polymers 
might also be immunogenic. Synthetic biocompatible and/or biodegradable polymers 
are widely used in surgical sutures and constructs for ex-vivo cell culturing, 
expansion and transplantation [100-102]. The most widely used synthetic bio-
polymers belong to the poly (α-hydroxy acid) family of polymers, including 
poly(lactic acid) (PLA), poly(glycolic acid) (PGA),  poly(D,L-lactide-co-glycolide) 
(PLGA), and their modified derivatives. Because of the wide range of the desirable 
physical properties, synthetic polymers can be precisely constructed in various 
formats of defined shape, morphology, and composition [103,104]. Their bio-
degradation can be controlled by their design and fabrication [105]. However, initial 
interaction between degradable scaffolds and seeded cells, as well as initial host 
response to tissue engineering devices, presents a critical challenge in the design of 
the synthetic polymers [99,106-108]. Finally, hybrid polymers are generally designed 
to achieve the desirable physical properties of synthetic polymers and the 
biocompatibility of natural bio-polymers. This may be achieved by chemically 
coupling bio-active components of natural substrates with synthetic polymers or 
chemically modifying bio-polymers to introduce desired physical properties 
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[99,109,110]. 
As for the present work, it was almost entirely based on the use and 
engineering of lactide derived biodegradable polymers as base materials. 
The reasons underlying this choice are not to be enclosed in a simple imitative 
model related to the widespread usage of these materials, at least not directly. 
Inevitably, the adoption of a "trendy" technological standard allows, more than 
others, to have at one's disposal a vast and readily available source of knowledge and 
tools that only experience could provide otherwise. In this optics, the access to a 
consolidated technological apparatus, like that of lactide-based polymers industry, is 
a necessary prerequisite for granting a solid starting base for any further 
advancement and contribution to the existing knowhow. 
Poly( lactic acid) (PLA) 
Poly(lactic acid), or polylactide, is a biodegradable, thermoplastic, aliphatic 
polyester. It is obtained by the ring-opening polymerization of lactide, the dimer of 
lactic acid (Fig. 2.3.1), which is produced from the bacterial fermentation of 
agricultural products and by-products.  
 
 
 
Fig 2.3.1: Synthesis of poly(lactic acid) (PLA) [111]. 
 
Lactide exists as two optical isomers, D and L. L-lactide is the naturally 
occurring isomer, and DL-lactide is the synthetic blend of D-lactide and L-lactide. 
The homo-polymer of L-lactide (PLLA) is a semi-crystalline polymer. These types 
of materials exhibit high tensile strenght and low elongation, and consequently have 
a high modulus that makes them more suitable for load bearing applications, such as 
in orthopedic fixation and sutures [102]. Poly(D,L-lactide) (PDLA) is an amorphous 
polymer exhibiting a random distribution of both isomeric forms of lactic acid, and 
accordingly is unable to arrange into an organized crystalline structure. This material 
has lower tensile strength, higher elongation, and a much more rapid degradation 
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time, making it more attractive as a drug delivery system[112-114]. 
PLA is about 37% crystalline, with a melting point of 175-178°C and a glass 
transition temperature of 60-65°C [49,115]. The degradation time of PLLA is much 
slower than that of PDLA, requiring more than a years to be completely adsorbed 
[116]. Co-polimers of L-lactide and DL-lactide have been prepared to disrupt the 
crystallinity of L-lactide and accelerate the degradation process [117,50]. 
With respect to soft and hard tissue repair, PLA has always been one of the 
most diffused biomaterials [118-121]. Until the late 1980s, application of PLA was 
limited to medical uses due to its high price. However, decreases in the production 
cost of lactic acid together with the improvements in the polymerization process, 
have led its commercial-scale production. Due to its chemical and mechanical 
stability, PLA is currently used in several biomedical and foodservice applications, 
while its “green” nature makes it a promising replacement for plastics like 
polyethylene terephthalate (PET) and polyvinyl chloride (PVC) for the sustainable 
packaging market [120]. Unlike most commercial polymers, the cost of PLA is not 
dependent on the production and price of oil, and is only determined by that of 
agricultural products like corn, tapioca, sugar cane and sugar beet. PLA is 
biodegradable in vivo, in the environment and in compost. Finally, high molecular 
weight PLA is rarely effected by fungi, mold, or other microbes at ordinary 
temperatures. 
 
 
Poly (lactic-co-glycolic acid) (PLGA) 
Poly(lactic-co-glycolic acid) is obtained by the co-polymerization of  the PLA 
and PGA monomers (see Fig. 2.3.2), through which it is possible to extend the range 
of homo-polymer properties of the starting materials [121]. 
Copolymers of glycolide with both L-lactide and DL-lactide have been 
developed for both device and drug delivery applications [102,113]. It is important to 
note that there is not a linear relationship between copolymer composition and the 
mechanical and degradation properties of the materials. As an example, a 50:50 
lactide-co-glycolide copolimer degrades faster than the base homopolymers [122].  
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Fig 2.3.2: Synthesis of poly(lactic-co-glycolic acid) (PLGA) [111]. 
 
This phenomenon is due to the disruptive activity exerted by the glycolic 
monomer which alters the regularity of the PLA polymer chain [117], resulting in a 
globally amorphous copolymer, i.e. PLGA. 
PLGA shows important advantages and drawback respect to PLLA. It’s much 
softer, easier to be degraded and  re-adsorbed by cells, with a much lower 
inflammatory response. Unfortunately, as the scaffold is required to be mechanically 
self-sustainable, even in the biological environments, in this work PLLA was 
generally preferred respect to pure PLGA for scaffold fabrication. 
In this work, the use of PLGA was limited to smooth film production or as 
base material for producing composite scaffolds, due to the possibility to enhance its 
weaker mechanical properties in vitro by nano-ceramics addition, while still 
preserving its higher suitability towards cellular systems. 
 
2.4 Porosity measurements  
 
Porosity measurements were performed onto round samples obtained from 
collected scaffold. Samples average thickness was measured by means of a dial 
micrometer (Rambold, Germany). The weight of each sample Ws was first measured 
using an analytical balance in order to get polymer’s effective volume Vo : 
 
 
 
 
being ρ0 the measured density of the purchased polymer, equal to 1.27 g*cm
−3
. 
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Scaffold open porosity, the only relevant for cell viability considerations, was 
derived by subtracting the value for scaffold closed porosity from that of the total 
porosity, both calculated using a density balance and applying Archimedes’ 
principle, through the following relationship: 
 
 
                                                                                                 
 
 
where ρ is the density calculated as the ratio of the weight and the volume of 
PLLA samples.  
The high hydrophobicity of PLLA added to capillary forces deriving from the 
sub-100 µm pore size make it impossible for water to spontaneously penetrate into 
the scaffold.  
If we consider the extremely low weight to apparent volume ratio for these 
structures it’s easy to imagine how they would receive a strong up thrust once 
immersed in the fluid, proportional to Vtot,, i.e., the volume occupied by the polymer 
and the total air (scaffold's total porosity): 
 
            
  
          
                                                        
 
 
and: 
  
     
    
       
                                                                                       
 
 
where W'' is the measured net up thrust, UTtot the total air contribution and '' is 
the fluid density, equal to 1.0 g*cm
-3
,in this case water. The samples were then 
immersed into absolute ethanol where they sank after around 30 minutes. the 
samples ware left soaking for 2 hours in order to ensure complete ethanol permeation 
30 
 
into the scaffolds. The difference between the expected scaffold weight in ethanol 
(Ws –        with respect to that measured after scaffold sinking in ethanol, W' was 
due to the up-thrust exerted by ethanol on the air trapped inside the scaffold 
(UTclosed), and thus is directly proportional to the scaffold closed porosity Vclosed, 
being: 
 
 
                  
         
                                               
 
 
 
And: 
 
 
        
       
       
                                                                                 
 
In which W’ is the soaked scaffold weight in ethanol and ρ’= 0.8 g/cm3 is 
ethanol density. The interconnected porosity was calculated as: 
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Fig 2.4.1:Analitical balance for porosity measurements 
 
2.5 Lithography 
 
Photolithography (or "optical lithography") is a process used in microfabrication to 
selectively remove parts of a thin film or the bulk of a substrate. It uses light to 
transfer a geometric pattern from a photo mask to a light-sensitive chemical 
"photoresist", or simply "resist," on the substrate. A series of chemical treatments then 
either engraves the exposure pattern into, or enables deposition of a new material in 
the desired pattern upon, the material underneath the photo resist. In complex 
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integrated circuits, for example a modern CMOS, a wafer will go through the 
photolithographic cycle up to 50 times. 
Photolithography shares some fundamental principles with photography in that the 
pattern in the etching resist is created by exposing it to light, either directly (without 
using a mask) or with a projected image using an optical mask. This procedure is 
comparable to a high precision version of the method used to make printed circuit 
boards. Subsequent stages in the process have more in common with etching than to 
lithographic printing. It is used because it can create extremely small patterns (down 
to a few tens of nanometers in size), it affords exact control over the shape and size of 
the objects it creates, and because it can create patterns over an entire surface cost-
effectively. Its main disadvantages are that it requires a flat substrate to start with, it is 
not very effective at creating shapes that are not flat, and it can require extremely 
clean operating conditions. 
The steps involved in the photolithographic process are wafer cleaning; barrier layer 
formation; photoresist application; soft baking; mask alignment; exposure and 
development; and hard-baking. 
2.5.1 Wafer cleaning, barrier formation and photoresist application 
In the first step, the wafers are chemically cleaned to remove particulate matter on the 
surface as well as any traces of organic, ionic, and metallic impurities. After cleaning, 
silicon dioxide, which serves as a barrier layer, is deposited on the surface of the 
wafer. After the formation of the SiO2 layer, photoresist is applied to the surface of 
the wafer. High-speed centrifugal whirling of silicon wafers is the standard method 
for applying photoresist coatings in IC manufacturing. This technique, known as 
"Spin Coating", produces a thin uniform layer of photoresist on the wafer surface. 
2.5.2 Positive and negative photoresist 
 
There are two types of photoresist: positive and negative. For positive resists, the 
resist is exposed with UV light wherever the underlying material is to be removed. In 
these resists, exposure to the UV light changes the chemical structure of the resist so 
that it becomes more soluble in the developer. The exposed resist is then washed 
away by the developer solution, leaving windows of the bare underlying material. In 
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other words, "whatever shows, goes." The mask, therefore, contains an exact copy of 
the pattern which is to remain on the wafer. 
 
Negative resists behave in just the opposite manner. Exposure to the UV light 
causes the negative resist to become polymerized, and more difficult to dissolve. 
Therefore, the negative resist remains on the surface wherever it is exposed, and the 
developer solution removes only the unexposed portions. Masks used for negative 
photoresists, therefore, contain the inverse (or photographic "negative") of the pattern 
to be transferred. The figure below shows the pattern differences generated from the 
use of positive and negative resist. 
Negative resists were popular in the early history of integrated circuit processing, but 
positive resist gradually became more widely used since they offer better process 
controllability for small geometry features. Positive resists are now the dominant type 
of resist used in VLSI fabrication processes. 
 
 
Fig. 2.5.2.1: Example of working process for positive and negative photo-resist 
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2.5.3 Soft-baking 
Soft-baking is the step during which almost all of the solvents are removed from the 
photoresist coating. Soft-baking plays a very critical role in photo-imaging. The 
photoresist coatings become photosensitive, or imageable, only after softbaking. 
Oversoft-baking will degrade the photosensitivity of resists by either reducing the 
developer solubility or actually destroying a portion of the sensitizer. Undersoft-
baking will prevent light from reaching the sensitizer. Positive resists are 
incompletely exposed if considerable solvent remains in the coating. This undersoft-
baked positive resists is then readily attacked by the developer in both exposed and 
unexposed areas, causing less etching resistance. 
2.5.4 Mask alignment and exposure 
One of the most important steps in the photolithography process is mask alignment. 
A mask or "photomask" is a square quartz plate with a patterned emulsion of metal 
film on one side. The mask is aligned with the wafer, so that the pattern can be 
transferred onto the wafer surface. Each mask after the first one must be aligned to the 
previous pattern. 
Once the mask has been accurately aligned with the pattern on the wafer's surface, the 
photoresist is exposed through the pattern on the mask with a high intensity ultraviolet 
light. There are three primary exposure methods: contact, proximity, and projection. 
They are shown in the figure below. 
 
Fig.2.5.4.1: Three principal methods of exposure: (from left to right) Contact, Proximity, Projection 
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2.5.4.1 Contact printing 
In contact printing, the resist-coated silicon wafer is brought into physical contact 
with the glass photomask. The wafer is held on a vacuum chuck, and the whole 
assembly rises until the wafer and mask contact each other. The photoresist is exposed 
with UV light while the wafer is in contact position with the mask. Because of the 
contact between the resist and mask, very high resolution is possible in contact 
printing (e.g. 1-micron features in 0.5 microns of positive resist). The problem with 
contact printing is that debris, trapped between the resist and the mask, can damage 
the mask and cause defects in the pattern. 
2.5.4.2 Proximity printing 
The proximity exposure method is similar to contact printing except that a small gap, 
10 to 25 microns wide, is maintained between the wafer and the mask during 
exposure. This gap minimizes (but may not eliminate) mask damage. Approximately 
2- to 4-micron resolution is possible with proximity printing. 
2.5.4.3 Projection printing 
Projection printing, avoids mask damage entirely. An image of the patterns on the 
mask is projected onto the resist-coated wafer, which is many centimeters away. In 
order to achieve high resolution, only a small portion of the mask is imaged. This 
small image field is scanned or stepped over the surface of the wafer. Projection 
printers that step the mask image over the wafer surface are called step-and-repeat 
systems. Step-and-repeat projection printers are capable of approximately 1-micron 
resolution. 
2.5.5 Development 
One of the last steps in the photolithographic process is development. Fig.2.5.5.1 
below, shows response curves for negative and positive resist after exposure and 
development. 
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Fig.2.5.5.1: (a) Resist exposure characteristics (b) Resist after development 
 
At low-exposure energies, the negative resist remains completely soluble in the 
developer solution. As the exposure is increased above a threshold energy Et, more of 
the resist film remains after development. At exposures two or three times the 
threshold energy, very little of the resist film is dissolved. For positive resists, the 
resist solubility in its developer is finite even at zero-exposure energy. The solubility 
gradually increases until, at some threshold, it becomes completely soluble. These 
curves are affected by all the resist processing variables: initial resist thickness, 
prebake conditions, developer chemistry, developing time, and others. 
2.5.6 Hard-baking 
Hard-baking is the final step in the photolithographic process. This step is necessary 
in order to harden the photoresist and improve adhesion of the photoresist to the wafer 
surface. 
 
2.5.7 Soft-lithography for tissue engineering 
Photolithographic technologies offer a broad and unique tool for scaffolds the 
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design and fabrication of complex geometries and working devices operating at the 
micro and nano-scales [123,124]. The recent years have witnessed an impressive 
explosion and growth of photolithography even in the area of TE, usually referred to 
as soft-lithography [40], since it also deals with materials, generally plastics, softer 
than silicon and others. In particular, soft-lithography comprises a set of techniques 
(spin casting and lamination [43], replica moulding [48], microfabrication [42], 
capillary micromoulding [41], etc.), which rely on the use of an elastomeric stamp or 
replica for transferring a particular pattern over a suitable biocompatible or 
biodegradable polymer. The replica can be prepared by casting the liquid pre-
polymer of an elastomer (like PDMS) over a master exhibiting a pre-designed 
patterned decoration on its surface. In this way, multiple copies of the highly 
complex structures in the master can be promptly obtained with nanometer 
resolution. A complex 3D architecture can be finally achieved by stacking the 
produced membranes in different orientations [48,43]. 
The incredible spatial resolution that can be achieved by these techniques 
(down to 100 nm) are such to confer to the engineered scaffold the highest aspect 
ratio which characterize living organs, below which only self assembly processes can 
arrive.  
 
2.6 Cell culture 
 
Human Mesenchymal Stem Cells (hMSC) were purchased from LONZA Group Ltd 
(Basel, CH) and cultured in Mesenchymal Stem Cell Basal Medium (MSCBM) 
according to manufacturer instructions. Human Umbilical Vein Endothelial Cells 
(HUVEC) were purchased from LONZA Group Ltd (Basel, CH) and cultured in 
Endothelial Basal Medium (EBM-2) according to manufacturer instructions. Before 
the setting up of hMSC-HUVEC co-culture, hMSC were stained with a vital dye to 
distinguish them from HUVEC. For this reason, hMSC were washed in sterile 
phosphate buffer saline (PBS) and incubated for 30 minutes in complete growth 
medium with Vybrant™ Red vital dye (concentration: 4 ml/ml). After two washings 
in PBS, stem cells were cultured for 24 hours in complete growth medium. 
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2.7 Cryostat 
 
Cryostat are used in medicine to cut histological slides. They are usually used in a 
process called frozen section histology. 
The cryostat is essentially an ultrafine "deli-slicer", called a microtome, placed in 
a freezer. The cryostat is usually a stationary upright freezer, with an external wheel 
for rotating the microtome.  
The temperature can be varied, depending on the tissue being cut - usually from 
minus 20 to minus 30 degree Celsius. The freezer is either powered by electricity, or 
by a refrigerant like liquid nitrogen. Small portable cryostats are available and can run 
off generators or vehicle inverters. To minimize unnecessary warming all necessary 
mechanical movements of the microtome can be achieved by hand via a wheel 
mounted outside the chamber. Newer microtomes have electric push button 
advancement of the tissue. The precision of the cutting is in micrometres. Tissue are 
sectioned as thin as 1 micrometre. Usual histology slides are mounted with a thickness 
of about 7 micrometres. Specimens that are soft at room temperature are mounted on 
a cutting medium (often made of egg white) on a metal "chuck", and frozen to cutting 
temperature (for example at -20 degrees C). Once frozen, the specimen on the chuck 
is mounted on the microtome. The crank is rotated and the specimen advances toward 
the cutting blade. Once the specimen is cut to a satisfactory quality, it is mounted on a 
warm (room temperature) clear glass slide, where it will instantaneously melt and 
adhere. The glass slide and specimen is dried with a dryer or air dried, and stained. 
The entire process from mounting to reading the slide takes from 10 to 20 minutes, 
allowing rapid diagnosis in the operating room. The cryostat can be used to cut 
histology and tissue slide outside of medicine, but the quality of the section is poor 
compared to standard fixed section wax mounted histology. 
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Chapter 3 
 
Experimental 
 
 
 
 
3.1 Sample realization 
3.1.1 Scaffold synthesis by thermally induced phase separation 
At the beginning of this work, the initial setup consisted of: 
- A chiller (Thomas® TRL107SLC) 
- A dewar 
- An aluminum holder (hollow cylinder) 
 
The heat exchanger part of the chiller is a circular serpentine connected to the 
compressor by a bendable tube. This serpentine is placed inside the dewar. Ethanol 
has been used as heat exchange liquid. 
 
Commercial PLLA (Mwa = 100,000 ÷ 150,000, Aldrich, USA) was dissolved 
in 1,4 dioxane (Aldrich, USA) at the fixed concentration of 4 wt%. The solution was 
cast into a circular teflon mold and left freezing for 4 days in a cold room at 
temperatures of  -50°C. For directional gradient induced TIPS, the solution-
containing mold was placed on top of the aluminum holder set at -30°C. After 
solidification, the sample was immersed into an 80% wt ethanol aqueous solution to 
leach out the solvent. It is worth to mention that, as the congealed solution was 
removed from the freezing chamber, its internal structure was completely formed and 
fixed in the solid state so that the ethanol bath temperature can only influence the 
speed of the dioxane extraction process. Nevertheless, under too high extracting 
temperatures, e.g. room temperature, dioxane change of state may occur, leading to 
localized polymer re-dissolution and loss of the pre-formed scaffold architecture. To 
avoid an excessively slow process while still preserving scaffold features, the 
extraction temperature was set -18°C for four days. Ethanol solution was finally 
removed by letting the scaffold in air for one day at room temperature. 
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One of the critical factor to obtain a good structured scaffold is the perfect 
perpendicularity between the polymer solution surface and the applied thermal 
gradient. 
To obtain this condition then, the aluminum holder must be accurately horizontally 
positioned. 
The need of manually positioning the sample mold, other operations and most of all 
the round shaped internal bottom of the dewar makes this task not easy. 
As said before, the time between the mold positioning and the start of freezing is 
really short, so it’s not possible to check the horizontality after positioning the mold. 
Moreover, removing the cap for too long leads to a rise of the bath temperature and 
increase of humidity, resulting in water condensation on the metal holder and 
alteration of the thermal interface. 
It is clear then, why some efforts have been made to researched a method to fix the 
holder in a horizontal position. 
 A first option was to weld a thin metal plate on the internal bottom surface of 
the dewar. This solution was put aside because of the high probability of damaging 
the dewar, in fact the heat of the welding can easily pierce the bottom of the dewar. 
 A second, mechanical, solution is represented in fig.3.1.1.1. 
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Fig.3.1.1.1: Scheme of the first device designed, aimed to obtain a horizontal plane inside the dewar 
 
 
42 
 
Three screws are used to aid the regulation of the horizontality of the support for the 
aluminum holder. 
Despite the easiness of the regulation this method wasn’t free from issues. To permit 
the escape of the three screws  it would have been needed a radical modification of 
the dewar cap, additionally the structure was not stiff enough to support the combined 
chiller serpentine and aluminum holder weight without some uncontrollable 
displacements. 
 Finally the method that has been chosen is represented in fig.3.1.1.2. 
An aluminum ring is conjunct on top of an inox steel ring of the same diameter 
through the use of screws. Both plates were perforated in several points to create a 
pattern able to permit the diffusion of convectional flows inside the ethanol bath. 
The so composed structure is fixed in horizontal position by a three-point-anchorage. 
Three inox steel spheres are pushed against the internal wall of the dewar by lowering 
the screws making the whole system fixed to the dewar. 
The role of the steel ring is of giving weight and thus stability. 
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Fig.3.1.1.2: Scheme of the device utilized to flatten the bottom of the dewar 
 
  
44 
 
3.1.2 Used molds 
 
In this work three types of molds have been used: 
- a small beaker-like Teflon mold 
- three Teflon molds of different geometrical shape 
- a new Teflon reactor (described in § 3.1.3) 
 
The small beaker molds were used at the beginning of the work and they also resulted 
convenient during the optimization of the process because of the possibility of utilize 
more than one per time thanks to their limited size and amount of chemicals required. 
 
 
 
Fig. 3.1.2.1: Scheme of the three different Teflon molds 
 
When the mold is putted inside the chiller, the solution in contact with the cold walls 
of the mold solidifies in a first amorphous layer and then in an ordered structure. 
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This amorphous layer reduces the amount of the sample that can be used so it was 
decided to try using new molds (Fig.3.1.2.1) to increase the ordered area. 
These new molds share the same base area and maintain the same bottom and wall 
thickness of the beaker-like molds to prevent uncontrolled behavior changes of the 
system. 
Furthermore we investigated any possible influence of the mold geometry respect of 
the order/disorder of the structure of the scaffolds. 
 
3.1.3 Design of a new reactor 
 
Due to the non significant differences between the previous mold types, it was 
designed a new reactor utilizing a different approach. 
The concept was to maximize the thermal insulation of the walls and the 
conductivity of the bottom, improving the control of the system by direct temperature 
measurement of the bottom. 
Since the working temperatures were quite low, it was decided to maintain the 
structure of the reactor as simple as possible, thus with the minimum of different 
materials to avoid thermal deformation problems. 
Another parameter that influenced the design was the small amount of available 
materials. 
The final solution was to utilize a Teflon rod and silicon wafers. 
The device has completely been realized by machining the Teflon rod. 
As shown in Fig.3.1.3.1, the reactor has a cylindrical geometry to reduce the 
loss of material during the machining and because a circular shape of the mold 
seemed the one with the best results. 
The reactor is composed of five components: 
- the Teflon body: 
o bottom part 
o middle part 
o cap 
- a poly-carbonate O-ring 
- a silicon wafer 
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Fig. 3.1.3.1: Scheme of the three parts of the Teflon reactor 
 
The bottom part presents a lower half composed of many foot stands and an 
upper half with a lodging in which the silicon wafer allocates. 
The hole through the entire piece, combined with the many small foot stands, allow a 
good circulation of the liquid that acts as heat exchanger. 
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Right under the level of the wafer there are four holes, which go through all the length 
of the wall, permitting the escape of air during the immersion of the reactor in the 
dewar, avoiding bubbles and a low efficiency in the extraction of heat. 
 
 
 
Fig. 3.1.3.2: 3D model of the assembled reactor 
 
The middle part has a one inch hole through all the length of the piece that is 
the actual mold in which the solution is poured in. 
On the bottom from the inside there are the O-ring lodging and going to the outside an 
air space that aids the thermal insulation. 
From one point at the internal end of the air chamber departs one hole that reaches the 
top of the piece. This hole permits the insertion of a thermocouple that can measure 
directly the temperature of the silicon wafer. 
The cap has one hole through all the length to avoid compression of the fluids 
(the mold isn’t completely filled with the scaffold forming solution) inside the mold 
during the closing down of the reactor or the decompression due to the low 
temperature during the chilling. 
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Fig. 3.1.3.3: Exploded view of the 3D model of the reactor 
 
3.1.4 Optimization of the process 
 
In this work several process parameters has been varied to investigate any change in 
the structure, morphology and mechanical properties of the scaffolds so obtained. 
We started from the following set-up and then changed one parameter per time. 
After finding the best value of the changed parameter by visual analysis (SEM) of the 
scaffold structure, this value was adopted in the set-up for the next parameters. 
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From bibliography, the starting parameter we adopted were: 
- Polymer (PLLA) concentration: 4,6 % wt in 1,4-dioxane 
- Time of chilling: 4 days 
- Temperature of chilling: -50 C° (temperature imposed to the 
chiller) 
- Time of leaching: 4-5 days 
 
The time of chilling has been varied as follows: 
- 32 hours 
- 28 hours 
- 24 hours 
- 20 hours 
- 16 hours 
- 12 hours 
 
After noticing that a good structure could be obtained after 12 hours we also 
investigate 
- 8 hours 
- 2,5 hours 
 
The leaching time has been varied as follows: 
- 48 hours 
- 44 hours 
- 40 hours 
- 36 hours 
- 32 hours 
- 28 hours 
 
The chilling temperature was investigated in this range (temperature imposed to the 
chiller): 
- - 70 C° 
- - 60 C° 
- - 50 C° 
- - 40 C° 
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- - 30 C° 
- - 20 C° 
 
As happened many times in science, serendipity came in our help. In fact, during a 
trial set-up without expectations of any significant results, we obtained an exceptional 
good structure at a high temperature respect of the above mentioned, thus we decided 
to focus on the following temperatures: 
- - 40 C° 
- - 30 C° 
- - 20 C° 
- - 10 C° 
 
The polymer concentration has been varied as follow: 
- 4 %wt 
- 3.5 %wt 
- 3 %wt 
- 2.5 %wt 
- 2 %wt 
 
Futhermore we investigate the effect of the mold’s shape: 
- Small beaker 
- Circular 
- Square 
- Exagonal 
- New reactor 
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3.1.5 Realized scaffolds 
 
The scaffolds realized during this work are listed in Tab.3.1.5.1. 
 
NAME Material CONCENTRATION Mold type TIPS T TIPS 
Time 
Leach
ing 
Time 
T26 PLLA 
0.11g in 2,3mL 
Dioxane 
Small 
Teflon 
beaker 
-26±1°C (Al) (-50 set) 
- Fatta taratura a tre 
terminali 
- Asciugato l’holder di 
Al 
3g 3 days 
T27 PLLA 
0.11g in 2,3mL 
Dioxane 
Small 
Teflon 
beaker 
-26±1°C (Al) (-50 set) 
- Fatta taratura a tre 
terminali 
- Asciugato l’holder di 
Al 
3g 3 days 
T28 PLLA 
0.11g in 2,3mL 
Dioxane 
Small 
Teflon 
beaker 
-28±1°C (Al) (-50 set) 
- Fatta taratura a tre 
terminali 
- Asciugato l’holder di 
Al 
46h 
3,5 
days 
T29 
PLLA/Ce
O2 
0.11g in 2,3mL 
Dioxane + 0.01g CeO2 
Small 
Teflon 
beaker 
-28±1°C (Al) (-50 set) 
- Fatta taratura a tre 
terminali 
- Asciugato l’holder di 
Al 
46h 
3,5 
days 
T30 
A 
round 
B 
square 
C 
hexag 
 
PLLA 
0.17g in 3,3mL 
Dioxane 
New 
molds of 
494 
mm
2
surfac
e area 
-28±1°C (Al) (-50 set) 
- Fatta taratura a tre 
terminali 
- Asciugato l’holder di 
Al 
3,5gg 3 days 
TIPS 
Si 
PLLA 
0,337g in 7,4 ml 
Dioxane 
Teflon 
reactor 
with Si 
wafer 
-58±1°C (Bagno 
EtOH) (-50 set) 
- Fatta taratura a un 
terminale 
48h 4 days 
T31 PLLA 
4ml of 5,1g in 10,9 ml 
Dioxane solution 
New 
square 
teflon 
mold 
-29±1°C (Al) (-50 set) 
- Fatta taratura a tre 
terminali 
- Asciugato l’holder di 
Al 
3gg 4 days 
T32 PLLA 
2,5ml of  5,1g in 10,9 
ml Dioxane solution 
New 
circular 
teflon 
mold 
-29±1°C (Al) (-50 set) 
- Fatta taratura a tre 
terminali 
- Asciugato l’holder di 
Al 
3gg 4 days 
T33 PLLA 
4ml of 5,1g in 10,9 ml 
Dioxane solution 
Small 
Teflon 
beaker 
-29±1°C (Al) (-50 set) 
- Fatta taratura a tre 
terminali 
- Asciugato l’holder di 
Al 
3gg 4 days 
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T34 
PLLA/Ce
O2 
0,15g+0,02g CeO2 in 
3,6ml Dioxane 
Small 
Teflon 
beaker 
-30±1°C (Al) (-50 set) 
- Fatta taratura a tre 
terminali 
- Asciugato l’holder di 
Al 
3,5g 4 days 
TIPS 
Si X 2 
PLLA 
0,15g in 3,6 ml 
Dioxane 
New 
Teflon 
Reactor 
9±1°C (Al) (-35 set) 
- Fatta taratura a due 
terminali 
- In livella 
1g 
4,5 
days 
T35 PLLA 
0,15g in 3,6 ml 
Dioxane 
Small 
Teflon 
beaker 
-10±1°C (Al) (-25 set) 
- Fatta taratura a tre 
terminali 
- Asciugato l’holder di 
Al 
21h 4 days 
T36 PLLA 
0,15g in 3,6 ml 
Dioxane 
New 
circular 
teflon 
mold 
-10±1°C (Al) (-25 set) 
- Fatta taratura a tre 
terminali 
- Asciugato l’holder di 
Al 
21h 4 days 
TIPS 
Si X 3 
PLLA 
0,3g in 7,2 ml 
Dioxane 
New 
Teflon 
Reactor 
10±1°C (Al) (-30 set) 
- Fatta taratura a due 
terminali 
- In livella 
16h 3 days 
T37 PLLA 
0,15g in 3,6 ml 
Dioxane 
Small 
Teflon 
beaker 
-10±1°C (Al) (-30 set) 
- Fatta taratura a tre 
terminali 
- Asciugato l’holder di 
Al 
16h 4 days 
T38 PLLA 
0,15g in 3,6 ml 
Dioxane 
Small 
Teflon 
beaker 
-10±1°C (Al) (-30 set) 
- Fatta taratura a tre 
terminali 
- Asciugato l’holder di 
Al 
20h 4 days 
T39 PLLA 
0,15g in 3,6 ml 
Dioxane 
Small 
Teflon 
beaker 
-10±1°C (Al) (-30 set) 
- Fatta taratura a tre 
terminali 
- Asciugato l’holder di 
Al 
24h 4 days 
T40 PLLA 
0,15g in 3,6 ml 
Dioxane 
Small 
Teflon 
beaker 
-10±1°C (Al) (-30 set) 
- Fatta taratura a tre 
terminali 
- Asciugato l’holder di 
Al 
12h 4 days 
T41 PLLA 
0,15g in 3,6 ml 
Dioxane 
Small 
Teflon 
beaker 
-10±1°C (Al) (-30 set) 
- Fatta taratura a tre 
terminali 
- Asciugato l’holder di 
Al 
28h 4 days 
T42 PLLA 
0,15g in 3,6 ml 
Dioxane 
Small 
Teflon 
beaker 
-10±1°C (Al) (-30 set) 
- Fatta taratura a tre 
terminali 
- Asciugato l’holder di 
Al 
32h 4 days 
TIPS 
Si X 4 
PLLA 
0,3g in 7,2 ml 
Dioxane 
New 
Teflon 
Reactor 
10±1°C (Al) (-30 set) 
- Fatta taratura a due 
terminali 
- In livella 
20h 3 days 
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T43 PLLA 
0,15g in 3,6 ml 
Dioxane 
Small 
Teflon 
beaker 
-10±1°C (Al) (-30 set) 
- Fatta taratura a tre 
terminali 
- Asciugato l’holder di 
Al 
20h 28h 
T44 PLLA 
0,15g in 3,6 ml 
Dioxane 
Small 
Teflon 
beaker 
-10±1°C (Al) (-30 set) 
- Fatta taratura a tre 
terminali 
- Asciugato l’holder di 
Al 
20h 32h 
T45 PLLA 
0,15g in 3,6 ml 
Dioxane 
Small 
Teflon 
beaker 
-10±1°C (Al) (-30 set) 
- Fatta taratura a tre 
terminali 
- Asciugato l’holder di 
Al 
8h 4 days 
T46 
PLLA/Ce
O2 
0,15g in 3,6ml 
Dioxane with 
dispersed CeO2 
Small 
Teflon 
beaker 
-10±1°C (Al) (-30 set) 
- Fatta taratura a tre 
terminali 
- Asciugato l’holder di 
Al 
24h 5 days 
T47 e 
bis 
PLLA 
0,13g in 3,6 ml 
Dioxane 
Small 
Teflon 
beaker 
-10±1°C (Al) (-30 set) 
- Fatta taratura a tre 
terminali 
- Asciugato l’holder di 
Al 
20h 4 days 
T48 e 
bis 
PLLA 
0,11g in 3,6 ml 
Dioxane 
Small 
Teflon 
beaker 
-10±1°C (Al) (-30 set) 
- Fatta taratura a tre 
terminali 
- Asciugato l’holder di 
Al 
20h 4 days 
T49 e 
bis 
PLLA 
0,09g in 3,6 ml 
Dioxane 
Small 
Teflon 
beaker 
-10±1°C (Al) (-30 set) 
- Fatta taratura a tre 
terminali 
- Asciugato l’holder di 
Al 
20h 4 days 
T50 e 
bis 
PLLA 
0,07g in 3,6 ml 
Dioxane 
Small 
Teflon 
beaker 
-10±1°C (Al) (-30 set) 
- Fatta taratura a tre 
terminali 
- Asciugato l’holder di 
Al 
20h 6 days 
TIPS 
Si X 5 
PLLA 
0,3g in 7,2 ml 
Dioxane 
New 
Teflon 
Reactor 
10±1°C (Al) (-30 set) 
- Fatta taratura a due 
terminali 
- In livella 
20h 3 days 
T51 e 
bis 
PLLA 
0,15g in 3,6 ml 
Dioxane 
Small 
Teflon 
beaker 
-10±1°C (Al) (-30 set) 
- Fatta taratura a tre 
terminali 
- Asciugato l’holder di 
Al 
20h 4 days 
TIPS 
Si X 6 
PLLA 
0,3g in 7,2 ml 
Dioxane 
New 
Teflon 
Reactor 
10±1°C (Al) (-30 set) 
- Fatta taratura a due 
terminali 
- In livella 
20h 3 days 
T52 e 
bis 
PLLA 
0,15g in 3,6 ml 
Dioxane 
Small 
Teflon 
beaker 
-5±1°C (Al) (-20 set) 
- Fatta taratura a tre 
terminali 
- Asciugato l’holder di 
Al 
20h 4 days 
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T53 e 
bis 
PLLA 
0,15g in 3,6 ml 
Dioxane 
Small 
Teflon 
beaker 
0±1°C (Al) (-10 set) 
- Fatta taratura a tre 
terminali 
- Asciugato l’holder di 
Al 
20h 4 days 
T54 e 
bis 
PLLA 
0,15g in 3,6 ml 
Dioxane 
Small 
Teflon 
beaker 
-20±1°C (Al) (-40 set) 
- Fatta taratura a tre 
terminali 
- Asciugato l’holder di 
Al 
20h 4 days 
T55 e 
bis 
PLLA 
0,10g in 3,6 ml 
Dioxane 
Small 
Teflon 
beaker 
-8±1°C (Al) (-30 set) 
- Fatta taratura a tre 
terminali 
- Asciugato l’holder di 
Al 
20h 4 days 
T55’ e 
bis 
PLLA 
0,10g in 3,6 ml 
Dioxane 
Small 
Teflon 
beaker 
-10±1°C (Al) (-30 set) 
- Fatta taratura a due 
terminali 
- In livella 
20h 4 days 
T37’ e 
bis 
PLLA 
0,15g in 3,6 ml 
Dioxane 
Small 
Teflon 
beaker 
-10±1°C (Al) (-30 set) 
- Fatta taratura a due 
terminali 
- In livella 
16h 4 days 
T42’ e 
bis 
PLLA 
0,15g in 3,6 ml 
Dioxane 
Small 
Teflon 
beaker 
-10±1°C (Al) (-30 set) 
- Fatta taratura a due 
terminali 
- In livella 
32h 4 days 
T47’ e 
bis 
PLLA 
0,15g in 3,6 ml 
Dioxane 
Small 
Teflon 
beaker 
-10±1°C (Al) (-30 set) 
- Fatta taratura a due 
terminali 
- In livella 
20h 4 days 
TIPS 
Si X 7 
PLLA/Ce
O2 
0,3g in 7,2 ml 
Dioxane with 
dispersed CeO2 
New 
Teflon 
Reactor 
-10±1°C (Al) (-30 set) 
- Fatta taratura a due 
terminali 
- In livella 
20h 4 days 
 
Tab.3.1.5.1: Realized scaffolds list 
 
 
3.1.6 Design of lithographic mask 
 
One of the reasons why we chose to use a silicon wafer as the bottom of the 
mold in the new reactor (§3.1.3) is because of the possibility of developing a 
lithographic pattern on it. 
The structure of the scaffold that we pursue is given by the dissolution of the polymer 
solvent, after that this is frozen. The solvent crystallize with the mechanism of 
formation and the shape of dendrites. 
With this lithographic pattern we tried to trigger the formation of an organized pattern 
of dendrites in the chilling sample to obtain a better structure of the scaffold that 
could be more suitable for cells. 
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Fig. 3.1.6.1: Scheme of the photolithographic pattern for the reactor 
 
After producing a good amount of scaffolds, the dimensions and distances between 
near pore channels has been analyzed thus has been decided to realize a 
photolithographic mask structured as in Fig.3.1.6.2 a) and b). 
 
 
(a) 
 
(b) 
Fig. 3.1.6.2: Scheme of the photolithographic mask; a) dimensions, b) pattern subdivision 
 
We designed various patterns to obtain square pillars with different size of the square 
side and different distance between the center of the squares. 
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Some of the patterns are positive to obtain wells instead of pillars (used photo-resist is 
negative). 
We also designed one pattern with a cross shape to mimic the dendrite shape. 
 
Match between patterns: 
- Influence of pillar size: 
o A,B and D 
o L and M 
- Influence of the shape: - B and C 
- Influence of the spacing: 
o  A,I,M and N 
o B and L 
- Influence between P/N: 
o A and G 
o B and E 
o F and L 
o D and H 
. 
The pattern design is explained in Tab.3.1.6.1 
 
Letter Side [m] Spacing [m] (from 
center to center) 
Positive / 
Negative 
Shape 
A 50 250 N Square 
B 100 250 N Square 
C 100 250 N Cross 
D 20 250 N Square 
E 100 250 P Square 
F 100 300 P Square 
G 50 250 P Square 
H 20 250 P Square 
I 50 150 N Square 
L 100 300 N Square 
M 50 300 N Square 
N 50 500 N Square 
 
Tab. 3.1.6.1: Photolithographic mask design 
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3.1.7 Realization of the photo mask 
 
A small amount of SU-8 was deposited on top of the silicon wafer. Immediately after 
the resist has been homogeneously distributed by spin coating technique. 
Spin-coating followed this path: from 0 to 3000 rpm in 5 sec, 3000 rpm constant per 
30 sec, from 3000 to 5000 rpm in 1 sec, 5000 constant per 5 sec and finally from 5000 
to 0 rpm in 5sec. Soft backing was run for 20 min at 45 °C. 
The edges of the wafer has been trenched removing the external ring with different 
thickness. The exposure was held for 70 seconds at 18,8 watt. 
Hard backing has been performed at 65 °C for 90 seconds and then at 90 °C for 5 
minutes. 
Finally, the wafer has been stirred in SU-8 developer for 15 minutes, rinsed in clean 
SU-8 developer for 60 seconds and dried with compressed air. 
 
 
 
Fig. 3.1.7.1: Picture of trials of pattern N and L 
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3.2 Scaffolds characterization 
 
3.2.1 Morphology and mechanical characterization 
 
3.2.1.1 Scanning electron microscopy (SEM) 
 
Scaffold morphology was mainly determined by optical and scanning electron 
microscopy (SEM) observations. The non-biologically treated scaffolds were 
mounted on aluminum stubs using adhesive conducting carbon tape and platinum 
sputtered for 40 seconds (EMITECH K500X, United Kingdom), prior to be observed 
in a field-emission scanning electron microscope (FE-SEM, HITACHI HIGH 
SU8000, Japan; FE-SEM, HITACHI HIGH S4800, Japan) operating at acceleration 
voltages of 1 ÷ 10 KV. Once cell seeded, PLLA scaffolds were subdued to cell 
fixation and dehydration prior to SEM investigation, to avoid damage of the UH 
vacuum chamber of the microscope. Briefly, cells were fixed by covering the 
scaffold with glutaraldeide (GA) 2,5% in self made phosphate buffer (PB) 0,1 M at 
pH 7.2 for 2 h and then washed several times in PB. The construct was further 
washed in PB and subsequently kept in PB-EtOH solution at increasing EtOH 
concentrations from 30% to 100%. Once dried in air, the sample was finally ready 
for metallization. 
 
3.2.1.2 Compression test 
 
Scaffold mechanical properties were investigated by means of compression 
testing. The main round sample was cut into cubes of 5-6 mm edge, being the pore 
channels side oriented either along or perpendicular to the sample holder. The cubes 
were mounted on a EZ-S 500N (SHIMADZU, Japan) universal tensile tester, inside 
an environmental chamber (CHROMO CHAMBER M-600FN, TAITEC, Japan) set 
at 37°C and compressed at speed rate of 3 mm·min
-1
. For each test, the tensile 
strength was normalized to the average sectional area of the relative sample. For each 
sample, the compression modulus (E) was obtained by averaging the measurements 
performed in triplicate or quadruplicate, being E derived from the elastic portion of 
the compression diagram in each measurement. Data plot and fitting were made 
using Microcal Origin 8.0 software. 
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Fig. 3.2.1.2.1: Utilized compression test machine 
 
 
 
3.2.1.3  Porosity measurements 
 
The procedure used to measure porosity is described in §2.4 
 
3.2.2 Biological validation 
 
The biological validation of the scaffolds was performed by two different techniques. 
In a first attempt, the cells were seeded onto 3D scaffolds using a novel, vacuum-
based technique aimed at obtaining inner layer perfusion, while in a second set of 
experiments, thin scaffold sections were obtained by cryostat processing and then 
seeded with the cells. Both procedures allowed the setup of cell cultures up to 7 days. 
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Fig. 3.2.2.1: Utilized cryostat 
 
 
 
3.2.2.1  Sample preparation for cryostat 
 
After removing the top and bottom part by cutting with a sharp blade, to obtain 
exposed channels on both the surfaces, the scaffold, has been gently ripped along the 
diameter. Then the sample has been immersed in an aqueous solution with 30% wt of 
sucrose solution. 
Once the scaffold had sunk in the solution, it could be treated to obtain a suitable 
sample for the cryostat. 
A small dewar has been filled with a small quantity of grinded dry ice and hexane. 
The scaffold has been placed on a small plate ladle with a small quantity of solution 
and put in contact with the surface of the melting dry ice. 
After freezing, the sample has been moved inside of rectangular shape metal ladle and 
covered with OCT (Optimal Cutting Temperature compound), immersed again in the 
dry ice and, when frozen, moved on top of the sample holder, previously covered with 
a layer of OCT, and placed inside the cryostat (Fig.3.2.2.1.1) (LEICA, Germany), 
kept at the fixed temperature of -20 °C to avoid re-melting of the including agent . 
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In order to obtain a more stable attachment of the sample to the holder, a small metal 
cold weight is pressed against the sample during the OCT hardening. 
When the sample froze it has been cut in slices of 60 m of thickness. The slices have 
been placed on petri-dish or microscope slide for a firs observation. 
 
3.2.2.2  Cell seeding on thin sections 
 
HUVEC and Vybrant-stained hMSC were co-cultured in EBM-2 medium onto poly-
styrene dishes or onto TIPS scaffold sections for 7 days. At this timepoint, the cells 
were washed twice in sterile PBS and fixed with a solution containing 
paraformaldehyde (PFA, concentration 4% in PBS) for 30 minutes at 4°C. 
Subsequently, cell membrane was permeabilized with TRITON X-100  
(SIGMA-Aldrich, Concorezzo, Italy) for 2 minutes, washed twice in PBS and 
incubated with 5% Bovine Serum Albumin (BSA) to avoid unspecific antibody 
staining. 
 
 
3.2.2.3  Sample preparation for 3D cell seeding 
 
The scaffold has been cut with a sharp blade removing the top and bottom part 
exposing the pore channels. Afterwards, it has been washed several times with 
ethanol, sterilized by UV light for 5 minutes per side and soaked in sterile cell 
medium at 37°C, 5% CO2. 
 
3.2.2.4  3D Cell seeding 
 
To achieve complete scaffold colonization, Vybrant-stained hMSC and HUVEC 
were forced to enter scaffold inner layers using a vacuum-based technique. Cells can 
access the inner part of the scaffold directly from the axial pores or by sliding 
through the surface ends of the lateral branches. However, as shown schematically in 
Fig.3.2.2.4.1, the infiltration process can be very different if performed from the 
bottom or the top scaffold surface, given the oriented fishbone structure of the pores. 
Referring to the fishbone cross section, the two possible mechanisms proposed are 
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visually described in Fig.3.2.2.4.1. When cells are forced within the scaffold from 
the top side, the surface terminal lamellae act like a multi-funneled structure, whose 
effect is to convoy the cell flux mainly into the vertical channels (Fig.3.2.2.4.1(a)). 
When cells are infiltrated from the bottom side (Fig.3.2.2.4.1(b)), the reverse-funnel 
configuration facilitates cell migration from the backbone channels to the side 
branches, leading to a more uniform cell distribution within the construct. Therefore, 
to improve an even cell distribution, the scaffold was positioned with its back face 
adjacent to the syringe inlet, both during normalization and seeding steps. 
3D dTIPS scaffold was positioned in a plastic syringe and locked by mean of PTFE 
rings. 
3D co-culture onto TIPS scaffolds was performed in EBM-2 medium for 7 days. At 
this timepoint, the cells were washed twice in sterile PBS and fixed with a solution 
containing paraformaldehyde (PFA, concentration 4% in PBS) for 30 minutes at 4°C. 
Subsequently, cell membrane was permeabilized with TRITON X-100  
(SIGMA-Aldrich, COncorezzo, Italy) for 2 minutes and incubated with 5% Bovine 
Serum Albumin (BSA) to avoid unspecific antibody staining. 
 
 
(a) 
 
(b) 
 
Fig. 3.2.2.4.1: Schematics of cellular infiltration mechanisms upon the application of a pressure 
gradient: (a) top surface inlet, (b) back surface inlet. 
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(a) 
 
(b) 
 
(c) 
Fig. 3.2.2.4.2: Scheme of the syringe cell seeding procedure: a) set-up; b) aspiration; c) expulsion 
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In Fig.3.2.2.4.2 is represented the syringe set-up and procedure utilized for the cell 
seeding. 
Fig.3.2.2.4.3 shows a dTIPS scaffold after 7DIV of cells culturing, after extraction 
from the culture dish (Fig. 3.2.2.4.3(a)) and after immersion in PFA for cell fixation. 
 
 
(a) 
 
(b) 
Fig. 3.2.2.4.3: Pictures of the scaffolds after cells seeding a) as extracted from the culture dish and b) 
soaked in PFA for cell fixation 
 
Dark pink regions visible in both figures over the samples correspond to the cell 
colonized areas, whose intensity can be related to the cell density within the 3D PLLA 
scaffolds. 
 
3.2.2.5  Immunofluorescence 
 
The samples were incubated for 2 hours with primary antibodies directed 
against alpha smooth muscle actin (ASMA) or von Willenbrand Factor (vWF). The 
first antibody was intended to stain actin filaments, thus highlighting cell morphology, 
while the latter is directed against a protein (vWF) exclusively expressed in 
endothelial cells. 
After massive washing in PBS, the samples were incubated with appropriate 
FITC-labelled secondary antibody. Nuclei were counterstained with 4’,6’-diamidino-
2-phenylindole (DAPI) for 2 minutes. The occurrence of specific signals was 
visualized under LEICA TCS-5 confocal microscope. 
  
65 
 
Chapter 4 
 
Results and discussion 
 
 
 
4.1 Morphological characterization 
 
4.1.1 Scaffold structure 
 
The processing method was directional TIPS to enhance the ordered 
configuration in the scaffold porosity. The scaffolds were initially fabricated by 
dTIPS from 6.4 wt% PLLA/dioxane solutions. The solution was put on a cold plate 
kept at -40°C, and thus the thermal gradient was applied from the bottom to the top 
of the solution free surface, in the perpendicular direction. 
During the work we varied the process parameters but the structure itself didn’t 
change. What changed were the dimensions of each part of this structure. 
 The scaffold’s macrostructure that can be observed const of a peripheral 
region, bottom, external borders and sometimes external ring on the surface, of non 
ordered units of the microstructure and a core region of highly ordered structure. 
The disorder of the peripheral region was due to the contact with the walls of the 
mold. 
Forcing the thermal gradient to only occur in the perpendicular direction 
resulted in the dioxane crystals coordination into densely packed vertical arrays. 
After the sample reached the thermal equilibrium at -40°C, the dioxane crystals were 
then dissolved in an EtOH/H2O bath at -18°C, and their fingerprints were left in the 
polymeric matrix.  
The processing was reliable and reproducible. The resulting porosity was 
characterized by a long-range ordered hierarchical structure. 
Fig.4.1.1.1 shows the SEM micrographs of the morphology of obtained scaffolds.  
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(a) 
 
(b) 
 
(c) 
Fig.4.1.1.1: SEM micrographs of scaffolds obtained by directional TIPS carried out at -40°C onto 6.4% 
PLLA in 1,4 dioxane solutions: (left to right, starting from the left upper corner) a) cross sectional view; b) 
top view of a PLLA scaffold prepared by dTIPS, 4,5 cm in diameter and 0.6 mm thick showing the circular 
pore arrangement observable at the macro-scale; c) top zoomed views of surface morphology resulting 
from the protrusion of the lamellae on the surface 
 
Starting from the cross sectional view (Fig.4.1.1.1 a)), one can observe an array 
of straight parallel channels of about 20 µm diameter (inset of Fig.4.1.1.1 a)) going 
across the entire scaffold thickness. Each channel exhibits side tubular branches of 
comparable diameter departing from the whole channel length at about 45 to 70 
degrees with respect to the channel axis.  
As a result, the observed cross sections assume a typical multiple fishbone-like pore 
arrangement, as depicted in the figure. 
The holes in Fig.4.1.1.1 correspond to the top (Fig.4.1.1.1 b) and c)) surfaces channel 
terminations. As visible, the channel section is characterized by a three-poled 
stingray-like shaped section.  
The pores are arranged in concentrical rows, which confer the scaffold a typical 
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surface fibrous texture on the 80 µm scale (Fig.4.1.1.1 b)). This peculiar arrangement 
is nothing but the consequence of the circular symmetry impressed by mold inner 
walls, which are responsible for triggering the heterogeneous nucleation of the 
solvent. 
Finally, if we observe the fracture line shown in the picture, it is possible to notice 
how the tail channel density in the cross section varies depending on the fracture 
plane orientation. In particular, the channels appear more densely packed in fracture 
planes perpendicular to the pore rows (radial direction) and less dense in those 
tangent to the row direction. 
In the case of directional TIPS,  the highly ordered configuration deriving from 
the processing conditions allowed a rational study of the scaffold morphology. From 
the combined electronic and optical microscopy analysis of the samples, it was 
possible to model the scaffold pore architecture and identify the single repetitive pore 
unit.  
The structure as a whole can be assumed as the stack of parallel planar fibers 
intimately in contact, each one representing an array of dendritic units co penetrating 
each other (Fig.4.1.1.2 a)). 
The single pore dendrite unit is evidenced in the SEM micrograph of 
Fig.4.1.1.2 b) and schematized by the simplified model of Fig.4.1.1.2 c), as the 
superposition of a number of polymeric lamellar layers (three, in Fig.4.1.1.2 b)), 
whose amount depends on the scaffold thickness. 
Each section of the pore unit, is constituted by three main lamellae which 
depart from the stingray sectioned central channel. Two of the lamellae elongate 
from the stingray wings in the row direction (y direction), towards the first 
neighboring pore unit, while the third one (generally shorter) departs from the 
stingray tail in the radial direction (x direction). 
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Fig:4.1.1.2: a) Exploded view of the schematics of the scaffold; b) SEM visualization of a surface 
terminating single PLLA dendritic unit obtained by dTIPS; c) Schematics of a three-layered segment of 
the unit: growth (z), in-row (y) and row-to-row (x) directions are indicated together with the 20° ÷ 45° 
lamellar bending. 
 
Referring to Fig.4.1.1.2 c), the parameters d and D were defined as the 
diameter of the minor pole of the channel section (stingray tail), and the channel 
cross-sectional largest dimension (stingray wing-to-wing aperture), respectively. 
The diagonal side channels observed in Fig.4.1.1.1 a) correspond to the inter-space 
between two adjacent lamellae in the vertical direction z. In this case their diameter 
is about 20 µm, thus comparable with d, but can decrease to 15 ÷ 18 µm in case of 
pronounced lamellar bending.  
The observation of the cross sections of the dTIPS samples, constantly 
evidence how, at the micron scale, the fracture of the scaffold tends to occur in 
correspondence of the necking point of the stingray tail, thus leaving the tail channel 
well exposed on the section plane. The tail channel diameter corresponds to d and 
can be easily measured. 
However, it must be noted that the main channel aperture D, which is always 
about three times larger than d, is the effective parameter that must be considered for 
cell accommodation evaluations. 
In Fig.4.1.1.3 are reported some examples of a well ordered structure, in 
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Fig.4.1.1.4 instead an example of a disordered structure. 
 
 
 
(a) 
 
(b) 
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(C) 
 
(d) 
Fig.4.1.1.3: Examples of well ordered structure of dTIPS scaffolds: a) TIPS 30 cross section; b) TIPS 
30 cross section; c) TIPS 39 cross section; d) TIPS Si X 2 surface 
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(a) 
 
(b) 
Fig.4.1.1.4: Examples of non ordered structure of dTIPS scaffolds: a) TIPS 49 cross section; b) TIPS 
49 cross section 
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4.1.2 Porosity measurements 
 
Porosity measurements were conducted as described in §2.4. 
 
The porosity values found for these scaffolds are reported in Tab.4.1.2.1. 
 
TIPS Ws [g] W' [g] W" [g] open [%] tot [%] closed [%] 
T37' 0.03505 0.013 0.4883 94.73345 94.72658 -0.00686 
T42' 0.05431 0.0156 0.7328 93.85251 94.56699 0.714477 
T47 0.05209 0.017 0.7935 94.81279 95.14945 0.336659 
T47' 0.04906 0.0162 0.7877 95.09119 95.38339 0.292208 
T48 0.03893 0.0144 0.6332 95.43801 95.43934 0.001333 
T49 0.03212 0.0122 0.6648 96.42714 96.37098 -0.05615 
T50 0.02447 0.0095 0.462 96.15341 96.03928 -0.11413 
T54 0.03645 0.014 0.4927 94.69668 94.57606 -0.12063 
T51 0.03065 0.0114 0.4236 94.70281 94.6871 -0.01571 
T52 0.0357 0.0136 0.5083 94.92188 94.83268 -0.0892 
T53 0.04065 0.0101 0.5644 93.68854 94.70988 1.021341 
T55 0.03054 0.0122 0.6441 96.60189 96.43554 -0.16635 
 
Tab.4.1.2.1: Measured values of porosity of selected scaffolds obtained by dTIPS 
 
As shown in Tab.4.1.2.1, values of total porosity settles around 94,5% ÷ 96,5% that 
is in line with values from other works on TIPS scaffold in bibliography. 
Open porosity values are ,almost in every case, bigger than total porosity, that of 
course is not possible.  
This error is due to air micro bubbles trapped under the scaffold during the W’ 
measurements. 
This is a clear sign of the really good interconnection of the porosity in the scaffolds 
and, with a good approximation is possible to affirm that open porosity assets around 
97% ÷ 98% of the total porosity. 
Therefore close porosity must be the remaining 2% ÷ 3%. 
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4.2 Mechanical characterization 
 
The mechanical properties of dTIPS scaffolds made during this work have been 
obtained by mean of compression test. 
The scaffolds has been cut into cubes of approximately 5 mm of side and then 
subjected to compression. 
The compression has been actuated both in the direction of the pore channels and in 
the direction perpendicular to them. 
An example of the mechanical behavior of the scaffolds in reported in Fig.4.2.1 and 
Fig.4.2.2. 
 
 
 
Fig.4.2.1: Stress-strain graphs of TIPS 54 in channel direction and perpendicular to channel direction 
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Fig.4.2.2: Stress-strain graphs of TIPS 37, TIPS 38, TIPS 39, TIPS 40, TIPS 41 and TIPS Si X 2 in 
channel direction 
 
From Stress-strain graphs is possible to notice how the behavior of dTIPS scaffolds 
aligns with the behavior of cellular materials. 
It’s quite easy to recognize a first linear elastic deformation, a plateau and the final 
densification. 
 
Estimations of the Young’s modulus have been made possible through the analysis of 
the Stress-strain curves as shown in Fig.4.2.3. 
Multiple samples of the same scaffold have been tested and arithmetical means have 
been calculated from the obtained values. 
Calculated values of dTIPS scaffolds Young’s modulus along the channel direction 
have been reported in Tab.4.2.1. 
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Fig.4.2.3: Linear fitting of the stress-strain curve of TIPS 38 along the direction of the channels 
 
 
 
NAME Young’s modulus [MPa] NAME Young’s modulus [MPa] 
T37' 2.93 T47 1.99 
T38 5.3 T51 3 
T39 6.79 T52 2.5 
T40 2.05 T53 2.89 
T41 6.62 T54 3.22 
Tsi X2 3.41   
 
Tab.4.2.1: Calculated values of dTIPS’s Young’s modulus of selected scaffolds along channel 
direction 
 
 
Young’s modulus values calculated for dTIPS scaffold assets between values of 2 
MPa and 7 MPa. These values are in line with other works on TIPS scaffolds reported 
in bibliography. 
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4.3 Influence of process parameters variation 
 
4.3.1 Influence of the chilling temperature 
 
The effect of chilling temperature has been observed by mean of changes in 
morphology, porosity and mechanical properties. 
In Fig.4.3.1.1 the behavior of total porosity in function of the chilling temperature is 
presented. 
 
 
 
Fig.4.3.1.1: Total porosity trend in function of chilling temperature 
 
As shown in Fig.4.3.1.1, the slight variation of porosity is not enough to be 
considered significant even if an increase of porosity with of the chilling temperature 
can be noticed. 
As previously mentioned, the mechanism of formation of the porosity results 
in dendrite-like cavities, which are the fingerprints of the crystallized solvent after 
leaching. 
What can be expected from such mechanism is the formation of a larger 
microstructure with the increase of the temperature. 
This phenomenon is clearly showed in Fig.4.3.1.2 and Fig.4.3.1.3. 
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(a) 
 
(b) 
 
(c) 
 
(d) 
 
Fig:4.3.1.2: a) TIPS 54, 110 m, -20 °C; b) TIPS 52, 150 m, -5 °C; c) TIPS 53, 200 m, 0 °C; d) TIPS Si X 2, 250 m, 9 °C 
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Fig.4.3.1.3: Total porosity trend in function of chilling temperature 
 
 
 
As is clearly observable, the dimension of the pore channels increase of almost 
150% going from the chilling temperature of -20 °C to 10 °C, that is just below the 
freezing point of 1,4-dioxane. 
 
In Fig.4.3.1.4, the behavior of the Young’s modulus in function of the chilling 
temperature is shown. 
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Fig.4.3.1.4: Young’s modulus trend in function of chilling temperature 
 
The chilling temperature appears not to have significant influence on scaffolds’ 
mechanical properties or at least it was not possible to find any simple correlation 
between these two parameters. 
 
 
4.3.2 Influence of the chilling time 
 
The effect of chilling time has been observed by mean of porosity measurements 
and mechanical properties. 
In Fig.4.3.2.1, the behavior of total porosity in function of the chilling temperature is 
presented. 
As shown in Fig.4.3.2.1, even in this case, variation of porosity as function of 
the chilling time is slight or not significant within the range considered.  
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Fig.4.3.2.1: Total porosity trend in function of chilling time 
 
 
 
 
 
Fig.4.3.2.1: Young’s modulus trend in function of chilling time 
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The variation in the porosity values as a function of the chilling time, was also 
found to be extremely is low in comparison to other works. Nevertheless, a deep 
difference in the pore size was observed between the samples obtained after 2,5h. 
 
In Fig.4.3.2.1 is reported the behavior of the Young’s modulus in function of a 
decreasing chilling time. 
The values of Young’s modulus vary in a range from 2 MPa to 7 MPa in 
accordance with values in other works on TIPS scaffolds. 
A clear increase of the elastic modulus is observed with the increase of the 
chilling time. 
This trend has to be imputed to the longer time at disposition for the expulsion of 
polymer, inside the solvent solution, during the freezing. The more polymer expelled 
the more the walls of the channel are micro-porosity free. Moreover, a prolonged 
expulsion of polymer causes the restriction of the pore lumen, accompanied by a 
thickening of the pore walls and thus an overall increase of the mechanical strength. 
 
4.3.3 Influence of the leaching time 
 
The optimization of the leaching time parameter resulted very difficult and in the 
end impossible. 
During this work we tried to reduce the original chilling time of 4 days but it quickly 
appeared impossible to find a repeatable time for good results. 
The most influent factor was the mold type utilized. The small beaker and the 
three geometric new molds (circle, square, hexagon) have a fixed bottom, so the 
diffusion of the EtOH aqueous solution during the leaching happened only from the 
top of the mold. 
This fact, most of the times, made impossible the extraction of the scaffolds from the 
molds, extending the leaching time and creating a concentration gradient of dioxane 
inside the scaffold. 
Forcing the extraction when the scaffold was still partially frozen always led to the 
damaging of the scaffold itself. 
As show in Fig.4.3.3.1 this could happen by ripping the frozen part from the defrosted 
part or, in the worst case, by the re-dissolution of the polymer in the dioxane high 
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concentration region that led to a shrinkage of the structure and the loss of micro-
structural order. 
 
 
 
 
Fig.4.3.3.1: Damaged scaffold after premature extraction from small beaker mold 
 
 
The leaching time for these two types of molds varied from 6 to 3 days. 
With the new reactor, the leaching process is sensibly shorter respect to the other to 
types. 
This fact it’s due to the possibility of removing the bottom part of the reactor and so 
permitting the diffusion of the EtOH aqueous solution from both the top and bottom 
surfaces. 
An average leaching time with the reactor assets around 2 days. 
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4.3.4 Polymer concentration 
 
The effect of the polymer concentration has been observed by mean of porosity 
measurements. 
In Fig.4.3.4.1 is presented the behavior of total porosity in function of the polymer 
concentration. 
 
 
 
Fig.4.3.4.1: Total porosity trend in function of the polymer concentration 
 
With respect to the PLLA wt% range here investigated, the values are in good 
accordance with literature values acquired at similar thermal conditions. 
The slight differences in the porosity values registered for the different samples 
(within 0.1%) are to be addressed to the very low concentration range explored in the 
work as compared to analogous works. 
Despite the small values variation is still possible to advise a decreasing trend of the 
total porosity with the rise of polymer concentration. 
This is totally comprehensible if we consider that for the same solution volume, an 
increase of the amount of polymer implies a reduction of the solvent content, and thus 
a reduction of the void content after leaching. 
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4.3.5 Mold geometry 
 
As described in §4.3.3 the mold geometry highly affects the efficiency of the 
leaching process. Depending on the possibility of opening the bottom of the mold the 
leaching process is shortened or extended. 
Another crucial factor that we observed was the facilitation of the formation of an 
ordered structure. 
What we noticed was that both the circular molds (small beaker and circular mold 
with increased area), and in less measure the square mold promote the ordered 
structure formation. 
The hexagonal mold instead, showed a low attitude at favoring the formation of 
any ordered structure. 
Fig.4.3.4.1 shows two examples of non ordered structures obtained with the 
hexagonal mold. 
 
 
(a) 
 
(b) 
 
Fig:4.3.1.2: a) TIPS 30 C cross section; b) TIPS 30 C cross section 
 
The best results have been obtained with the new reactor. Both the possibility of 
removing the bottom and the improved thermal insulation helped in the obtaining of a 
very well ordered structure. 
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4.4 Biological validation 
 
4.4.1 Preparation of hMSC / HUVEC co-culture as stem cell 
differentiation system in standard poly-styrene dishes 
 
Before setting up three-dimensional co-cultures, human Mesenchymal Stem 
Cells (hMSC) and human Umbilical Vein Endothelial Cells (HUVEC) were co-
cultured in Endothelial Basal Medium 2 (EBM-2) onto standard culture poly-styrene 
dishes. Preliminary experiments showed that it was indeed possible to distinguish 
red-labelled hMSC and HUVEC on the basis of alpha smooth muscle actin (SMA, 
green), which is expressed in both cell types (Fig.4.4.1.1) and von Willenbrand 
Factor (vWF, green) which is known as an esclusive endothelial cell marker.  
 
 
 
Fig:4.4.1.1: Setup of co-culture differentiation system between hMSC and HUVEC cells: Alpha 
smooth muscle actin (green) expression in vybrant hMSC (red) and human umbilical vein endothelial 
cells, co-cultured in standard conditions. Nuclei are counterstained in blue. The picture shows the 
cytoskeleton arrangement in the two human cell types tested 
 
Seven day co-culture in standard dishes demonstrate that hMSC acquire vWF 
expression when co-cultured with HUVEC cells in EBM-2 medium (Fig.4.4.1.2). 
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Fig:4.4.1.2: hMSC endothelial differentiation in co-culture system: Expression of endothelial-specific 
marker von Willenbrand Factor (vWF, green) in human Mesenchymal stem Cells (hMSC, red), co-
cultured for 7 days with human umbilical vein endothelial cells (HUVEC) in standard culture 
conditions. The presence of red cells showing vWF green staining demonstrates stem cell succesfull 
differentiation towards the endothelial phenotype 
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4.4.2 3D cell co-culture and stem cell differentiation towards endothelial 
phenotype 
 
Scaffold thin sections were sterilized by ethanol washings and soaked in 
Endothelial Basal Medium 2 (EBM-2) for 24 hours. At this time-point, human 
mesenchymal stem cells (hMSC) were stained with red Vybrant vital dye and mixed 
with human umbilical vein endothelial cells (HUVEC) in 1:5 ratio. 
Therefore, they were co-seeded onto the scaffolds and on thin sections. Scanning 
electron microscope (SEM) micrographs taken after 7 days showed the ability of 
human cells to adhere functionally and survive onto the scaffolds and thin sections as 
demonstrated by the massive secretion of extracellular matrix (ECM) all over the 
structure (Fig. 4.4.2.1).  
 
 
 
 
(a) 
 
(b) 
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(c) 
 
(d) 
Fig:4.4.2.1: Human mesenchymal stem cells (hMSC) and human umbilical vein endothelial cells co-cultured 
for 7 days onto TIPS scaffold thin sections show the ability to adhere functionally, bridge over the pores and 
grow inside the channels a), b). SEM micrographs display the massive production of extracellular matrix 
(ECM) c), d). 
 
 
Nuclei staining demonstrated cell massive colonization of 3D porous structure 
and their aligninment inside the pores. Immunofluorescence analysis for Vybrant 
vital dye (Fig.4.4.2.2 red) and von Willenbrand Factor (vWF, green) further 
demonstrated the successful setup of co-cultures within 3D scaffolds and thin 
sections (Fig.4.4.2.2). Finally, when deeper examination of 3D co-culture specimens 
was conducted, human mesenchymal stem cell differentiation towards endothelial 
phenotype was confirmed on 3D scaffolds and thin sections, as shown by vWF 
staining (green) in vibrant-labelled cells (red, Fig.4.4.2.3). 
As reported in previous investigations on 3D scaffolds, SEM and 
immunofluorescence analyses are known to underestimate cell presence in the 
samples. This is mainly due to specimen manipulation and processing. In particular, 
such problems derive from the severe dehydration required for sample preparation in 
the case of SEM analysis, while the peeling-off of exposed surface cellular layers is 
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known to occur when cells are exposed to the repeated washings required for 
immunofluorescence analysis. Moreover, the gold layer deposition required for SEM 
analysis causes cell flattening and consequent loss of important cellular features, 
which also makes it hard to distinguish cells from the underlying polymer substrate.  
 
 
 
 
Fig:4.4.2.2: Massive cell colonization of scaffold thin sections: Low magnification image of scaffold 
thin section seeded for 7 days with human mesenchymal stem cells (hMSC, red) and human umbilical 
vein endothelial cells (HUVEC). Von Willenbrand Factor (vWF) protein staining (green) in red cells 
accounts for successful stem cell differentiation towards endothelial phenotype 
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Fig:4.4.2.3: hMSC differentiate towards endothelial phenotype when co-cultured for 7 days onto TIPS 
thin sections with HUVEC cells: High magnification images showing scaffold thin section seeded for 7 
days with human mesenchymal stem cells (hMSC, red) and human umbilical vein endothelial cells 
(HUVEC). Von Willenbrand Factor (vWF) protein staining (green) in red cells accounts for successful 
stem cell differentiation towards endothelial phenotype 
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Chapter 5 
 
Conclusions 
 
 
 
 
5.1  Conclusions 
 
With this work we demonstrated that it is possible to tailor the pore architecture 
of 3D polymer scaffold made by dTIPS. 
Morphologic and geometric characteristics of such scaffolds are in the optimal range 
for promoting the adhesion and growth of a wide field of cells type. 
These scaffolds show a mean overall porosity value of 95% and a grade of pore 
interconnection over 90%. 
So far, experimental data show that small pore dimensions are obtained with the 
maximum cooling time, the lowest cooling temperature and the highest polymer 
concentration, in the range of investigated values. 
Maximum pore diameters instead, are obtained applying a short cooling time, keeping 
the cooling temperature right under the freezing point of the dioxane and lowering the 
polymer concentration. 
Young’s modulus evaluated from compression test of scaffold samples vary in the 
range of 1 to 8 MPa in according to similar works in bibliography. 
An increasing of the elastic modulus has been observed with the increase of the 
cooling time. 
Biological validation has been tested by mean of cell seeding on scaffold’s thin 
sections and directly on tridimensional sections up to 5 mm. 
After 7 DIV (days in vitro) of culture, a massive colonization has been detected on the 
thin sections and the tridimensional sections both. 
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5.2  Prospectives 
 
The principal aim of these scaffolds is the realization of a vascular framework inside a 
regenerated tissue. 
To obtain this goal, future research will try to obtain a vascularized tissue, stacking 
tissues obtained with scaffold thin sections, one on top of each other. 
More tests will be performed, trying to trigger the nucleation of dendrites, utilizing 
the reactor and the elaborated silicon wafer. 
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